	Query	Target	Query-Cov	Align-From	Align-To	1-Candidate	1-Mol.Name	1-Reg.Status	2-Candidate	2-Mol.Name	2-Reg.Status	Similarity by Tcoff
0	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB02482	Phosphonothreonine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB05169	AT9283	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
2	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB05198	CYC116	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
3	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB05220	Alisertib	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
4	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB06134	SNS-314	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
5	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB06347	Cenisertib	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
6	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB06486	Enzastaurin	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
7	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB07186	4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
8	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB07266	AKI-001	experimental	DB00200	Hydroxocobalamin	approved	0.71
9	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB07266	AKI-001	experimental	DB00309	Vindesine	approved; investigational	0.7
10	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB07266	AKI-001	experimental	DB00361	Vinorelbine	approved; investigational	0.71
11	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB07266	AKI-001	experimental	DB00541	Vincristine	approved; investigational	0.71
12	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB07266	AKI-001	experimental	DB00570	Vinblastine	approved	0.71
13	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB07266	AKI-001	experimental	DB03614	Mecobalamin	approved; investigational	0.7
14	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB07266	AKI-001	experimental	DB11191	Cobamamide	approved	0.71
15	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB07266	AKI-001	experimental	DB11641	Vinflunine	approved; investigational	0.71
16	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB07360	1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
17	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB07362	1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
18	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB07545	N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
19	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB07801	N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
20	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB08065	2-(1H-pyrazol-3-yl)-1H-benzimidazole	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
21	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB08066	N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
22	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
23	sp|O14965|AURKA_HU	O14965	99.75	1.0	403.0	DB13061	MLN8054	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
24	sp|O14965|AURKA_HU	P51812	79.16	11.0	330.0	DB00945	Acetylsalicylic acid	approved; vet_approved	DB00945	Acetylsalicylic acid	approved; vet_approved	1.0
25	sp|O14965|AURKA_HU	P51812	79.16	11.0	330.0	DB00945	Acetylsalicylic acid	approved; vet_approved	DB08814	Triflusal	approved; investigational	0.74
26	sp|O14965|AURKA_HU	P51812	79.16	11.0	330.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
27	sp|O14965|AURKA_HU	P51812	70.22	412.0	695.0	DB00945	Acetylsalicylic acid	approved; vet_approved	DB00945	Acetylsalicylic acid	approved; vet_approved	1.0
28	sp|O14965|AURKA_HU	P51812	70.22	412.0	695.0	DB00945	Acetylsalicylic acid	approved; vet_approved	DB08814	Triflusal	approved; investigational	0.74
29	sp|O14965|AURKA_HU	P51812	70.22	412.0	695.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
30	sp|O14965|AURKA_HU	O75676	71.96	13.0	303.0	DB03247	Flavin mononucleotide	approved; investigational	DB00140	Riboflavin	approved; investigational; nutraceutical; vet_approved	0.96
31	sp|O14965|AURKA_HU	O75676	71.96	13.0	303.0	DB03247	Flavin mononucleotide	approved; investigational	DB03147	Flavin adenine dinucleotide	approved	0.79
32	sp|O14965|AURKA_HU	O75676	71.96	13.0	303.0	DB03247	Flavin mononucleotide	approved; investigational	DB03247	Flavin mononucleotide	approved; investigational	1.0
33	sp|O14965|AURKA_HU	P23458	73.7	850.0	1147.0	DB02375	Myricetin	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
34	sp|O14965|AURKA_HU	P23458	73.7	850.0	1147.0	DB04716	2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
35	sp|O14965|AURKA_HU	P23458	73.7	850.0	1147.0	DB08877	Ruxolitinib	approved	DB08877	Ruxolitinib	approved	1.0
36	sp|O14965|AURKA_HU	P23458	73.7	850.0	1147.0	DB08895	Tofacitinib	approved; investigational	DB08895	Tofacitinib	approved; investigational	1.0
37	sp|O14965|AURKA_HU	P23458	73.7	850.0	1147.0	DB11817	Baricitinib	approved; investigational	DB11817	Baricitinib	approved; investigational	1.0
38	sp|O14965|AURKA_HU	P23458	73.7	850.0	1147.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
39	sp|O14965|AURKA_HU	P23458	73.7	850.0	1147.0	DB12500	Fedratinib	approved; investigational	DB12500	Fedratinib	approved; investigational	1.0
40	sp|O14965|AURKA_HU	P23458	73.7	850.0	1147.0	DB15091	Upadacitinib	approved; investigational	DB15091	Upadacitinib	approved; investigational	1.0
41	sp|O14965|AURKA_HU	P29597	70.22	582.0	865.0	DB04716	2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
42	sp|O14965|AURKA_HU	P29597	70.22	582.0	865.0	DB08895	Tofacitinib	approved; investigational	DB08895	Tofacitinib	approved; investigational	1.0
43	sp|O14965|AURKA_HU	P29597	70.22	582.0	865.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
44	sp|O14965|AURKA_HU	Q9BYT3	92.06	17.0	388.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
45	sp|O14965|AURKA_HU	Q7KZI7	73.95	10.0	308.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
46	sp|O14965|AURKA_HU	P27448	74.94	12.0	314.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
47	sp|O14965|AURKA_HU	P31751	75.68	108.0	413.0	DB07812	N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
48	sp|O14965|AURKA_HU	P31751	75.68	108.0	413.0	DB07859	4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
49	sp|O14965|AURKA_HU	P31751	75.68	108.0	413.0	DB07947	ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
50	sp|O14965|AURKA_HU	P31751	75.68	108.0	413.0	DB08073	(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
51	sp|O14965|AURKA_HU	Q9P0L2	72.7	25.0	318.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
52	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB00171	ATP	investigational; nutraceutical	DB00118	Ademetionine	approved; investigational; nutraceutical	0.79
53	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB00171	ATP	investigational; nutraceutical	DB00131	Adenosine phosphate	approved; investigational; nutraceutical	0.93
54	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB00171	ATP	investigational; nutraceutical	DB00157	NADH	approved; nutraceutical	0.82
55	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB00171	ATP	investigational; nutraceutical	DB00194	Vidarabine	approved; investigational	0.87
56	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB00171	ATP	investigational; nutraceutical	DB00242	Cladribine	approved; investigational	0.76
57	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB00171	ATP	investigational; nutraceutical	DB00631	Clofarabine	approved; investigational	0.72
58	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB00171	ATP	investigational; nutraceutical	DB00640	Adenosine	approved; investigational	0.87
59	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB00171	ATP	investigational; nutraceutical	DB01073	Fludarabine	approved	0.83
60	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB00171	ATP	investigational; nutraceutical	DB01280	Nelarabine	approved; investigational	0.73
61	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB00171	ATP	investigational; nutraceutical	DB03147	Flavin adenine dinucleotide	approved	0.73
62	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB00171	ATP	investigational; nutraceutical	DB05528	Mipomersen	approved; investigational	0.7
63	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB00171	ATP	investigational; nutraceutical	DB06213	Regadenoson	approved; investigational	0.74
64	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB00171	ATP	investigational; nutraceutical	DB06441	Cangrelor	approved	0.77
65	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB00171	ATP	investigational; nutraceutical	DB13156	Inosine pranobex	approved	0.7
66	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB01169	Arsenic trioxide	approved; investigational	DB01169	Arsenic trioxide	approved; investigational	1.0
67	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB01645	Genistein	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
68	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB01863	Inositol 1,3,4,5-Tetrakisphosphate	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
69	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB02709	Resveratrol	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
70	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB05971	Archexin	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
71	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB06486	Enzastaurin	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
72	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB06641	Perifosine	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
73	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB07584	N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
74	sp|O14965|AURKA_HU	P31749	75.19	106.0	409.0	DB07585	5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
75	sp|O14965|AURKA_HU	O00141	76.43	47.0	355.0	DB03247	Flavin mononucleotide	approved; investigational	DB00140	Riboflavin	approved; investigational; nutraceutical; vet_approved	0.96
76	sp|O14965|AURKA_HU	O00141	76.43	47.0	355.0	DB03247	Flavin mononucleotide	approved; investigational	DB03147	Flavin adenine dinucleotide	approved	0.79
77	sp|O14965|AURKA_HU	O00141	76.43	47.0	355.0	DB03247	Flavin mononucleotide	approved; investigational	DB03247	Flavin mononucleotide	approved; investigational	1.0
78	sp|O14965|AURKA_HU	O00141	76.43	47.0	355.0	DB07837	[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
79	sp|O14965|AURKA_HU	O00141	76.43	47.0	355.0	DB08191	4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
80	sp|O14965|AURKA_HU	Q8IU85	71.22	8.0	295.0	DB08454	N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
81	sp|O14965|AURKA_HU	Q8IU85	71.22	8.0	295.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
82	sp|O14965|AURKA_HU	Q02156	83.62	333.0	670.0	DB06064	KAI-1455	investigational	DB12010	Fostamatinib	approved; investigational	1.0
83	sp|O14965|AURKA_HU	Q02156	83.62	333.0	670.0	DB11752	Bryostatin 1	investigational	DB12010	Fostamatinib	approved; investigational	1.0
84	sp|O14965|AURKA_HU	Q02156	83.62	333.0	670.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
85	sp|O14965|AURKA_HU	Q02156	83.62	333.0	670.0	DB00675	Tamoxifen	approved	DB00539	Toremifene	approved; investigational	0.94
86	sp|O14965|AURKA_HU	Q02156	83.62	333.0	670.0	DB00675	Tamoxifen	approved	DB00675	Tamoxifen	approved	1.0
87	sp|O14965|AURKA_HU	Q02156	83.62	333.0	670.0	DB00675	Tamoxifen	approved	DB04938	Ospemifene	approved; investigational	0.86
88	sp|O14965|AURKA_HU	Q9P286	85.61	356.0	701.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
89	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB00144	Phosphatidyl serine	approved; investigational; nutraceutical	DB00144	Phosphatidyl serine	approved; investigational; nutraceutical	1.0
90	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB00144	Phosphatidyl serine	approved; investigational; nutraceutical	DB09114	Colfosceril palmitate	approved; investigational; withdrawn	0.75
91	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB00144	Phosphatidyl serine	approved; investigational; nutraceutical	DB11283	DL-dimyristoylphosphatidylcholine	approved	0.75
92	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB00144	Phosphatidyl serine	approved; investigational; nutraceutical	DB11284	DL-dimyristoylphosphatidylglycerol	approved	0.76
93	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB00144	Phosphatidyl serine	approved; investigational; nutraceutical	DB11331	1-Palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol))	approved; experimental	0.73
94	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB00144	Phosphatidyl serine	approved; investigational; nutraceutical	DB14096	1,2-icosapentoyl-sn-glycero-3-phosphoserine	approved; experimental	0.87
95	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB00144	Phosphatidyl serine	approved; investigational; nutraceutical	DB14099	1,2-Distearoyllecithin	approved; experimental	0.75
96	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB00144	Phosphatidyl serine	approved; investigational; nutraceutical	DB14105	Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol)	approved; experimental	0.76
97	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB00163	Vitamin E	approved; nutraceutical; vet_approved	DB00163	Vitamin E	approved; nutraceutical; vet_approved	1.0
98	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB00163	Vitamin E	approved; nutraceutical; vet_approved	DB14001	alpha-Tocopherol succinate	approved; nutraceutical; vet_approved	0.88
99	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB00163	Vitamin E	approved; nutraceutical; vet_approved	DB14002	D-alpha-Tocopherol acetate	approved; nutraceutical; vet_approved	0.92
100	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB00163	Vitamin E	approved; nutraceutical; vet_approved	DB14476	DL-alpha-Tocopherol	approved; experimental; investigational	1.0
101	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB05013	Ingenol mebutate	approved	DB05013	Ingenol mebutate	approved	1.0
102	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06451	Aprinocarsen	investigational	DB00157	NADH	approved; nutraceutical	0.71
103	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06451	Aprinocarsen	investigational	DB00200	Hydroxocobalamin	approved	0.74
104	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06451	Aprinocarsen	investigational	DB00309	Vindesine	approved; investigational	0.71
105	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06451	Aprinocarsen	investigational	DB00361	Vinorelbine	approved; investigational	0.72
106	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06451	Aprinocarsen	investigational	DB00541	Vincristine	approved; investigational	0.72
107	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06451	Aprinocarsen	investigational	DB00570	Vinblastine	approved	0.72
108	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06451	Aprinocarsen	investigational	DB03147	Flavin adenine dinucleotide	approved	0.71
109	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06451	Aprinocarsen	investigational	DB03614	Mecobalamin	approved; investigational	0.74
110	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06451	Aprinocarsen	investigational	DB05528	Mipomersen	approved; investigational	0.76
111	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06451	Aprinocarsen	investigational	DB11191	Cobamamide	approved	0.74
112	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06451	Aprinocarsen	investigational	DB11641	Vinflunine	approved; investigational	0.72
113	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06451	Aprinocarsen	investigational	DB12674	Lurbinectedin	approved; investigational	0.72
114	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB00115	Cyanocobalamin	approved; nutraceutical	0.73
115	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB00200	Hydroxocobalamin	approved	0.77
116	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB00290	Bleomycin	approved; investigational	0.71
117	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB00309	Vindesine	approved; investigational	0.74
118	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB00361	Vinorelbine	approved; investigational	0.76
119	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB00541	Vincristine	approved; investigational	0.75
120	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB00570	Vinblastine	approved	0.75
121	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB00762	Irinotecan	approved; investigational	0.71
122	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB00970	Dactinomycin	approved; investigational	0.71
123	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB03614	Mecobalamin	approved; investigational	0.76
124	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB04911	Oritavancin	approved; investigational	0.71
125	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB05109	Trabectedin	approved; investigational	0.72
126	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB06402	Telavancin	approved	0.71
127	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB06595	Midostaurin	approved; investigational	1.0
128	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB11191	Cobamamide	approved	0.77
129	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB11641	Vinflunine	approved; investigational	0.76
130	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB11691	Naldemedine	approved; investigational	0.72
131	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06595	Midostaurin	approved; investigational	DB12674	Lurbinectedin	approved; investigational	0.74
132	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB06641	Perifosine	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
133	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB08846	Ellagic acid	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
134	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB11752	Bryostatin 1	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
135	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB14001	alpha-Tocopherol succinate	approved; nutraceutical; vet_approved	DB00163	Vitamin E	approved; nutraceutical; vet_approved	0.88
136	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB14001	alpha-Tocopherol succinate	approved; nutraceutical; vet_approved	DB14001	alpha-Tocopherol succinate	approved; nutraceutical; vet_approved	1.0
137	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB14001	alpha-Tocopherol succinate	approved; nutraceutical; vet_approved	DB14002	D-alpha-Tocopherol acetate	approved; nutraceutical; vet_approved	0.95
138	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB14001	alpha-Tocopherol succinate	approved; nutraceutical; vet_approved	DB14476	DL-alpha-Tocopherol	approved; experimental; investigational	0.88
139	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB14002	D-alpha-Tocopherol acetate	approved; nutraceutical; vet_approved	DB00163	Vitamin E	approved; nutraceutical; vet_approved	0.92
140	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB14002	D-alpha-Tocopherol acetate	approved; nutraceutical; vet_approved	DB14001	alpha-Tocopherol succinate	approved; nutraceutical; vet_approved	0.95
141	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB14002	D-alpha-Tocopherol acetate	approved; nutraceutical; vet_approved	DB14002	D-alpha-Tocopherol acetate	approved; nutraceutical; vet_approved	1.0
142	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB14002	D-alpha-Tocopherol acetate	approved; nutraceutical; vet_approved	DB14476	DL-alpha-Tocopherol	approved; experimental; investigational	0.92
143	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB00675	Tamoxifen	approved	DB00539	Toremifene	approved; investigational	0.94
144	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB00675	Tamoxifen	approved	DB00675	Tamoxifen	approved	1.0
145	sp|O14965|AURKA_HU	P17252	72.21	310.0	601.0	DB00675	Tamoxifen	approved	DB04938	Ospemifene	approved; investigational	0.86
146	sp|O14965|AURKA_HU	P62344	78.16	23.0	338.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
147	sp|O14965|AURKA_HU	Q8IBS5	80.15	13.0	336.0	DB11638	Artenimol	experimental; investigational	DB06697	Artemether	approved	0.99
148	sp|O14965|AURKA_HU	Q8IBS5	80.15	13.0	336.0	DB11638	Artenimol	experimental; investigational	DB09274	Artesunate	approved; investigational	0.9
149	sp|O14965|AURKA_HU	Q8IBS5	80.15	13.0	336.0	DB11638	Artenimol	experimental; investigational	DB13851	Artemotil	approved	0.99
150	sp|O14965|AURKA_HU	Q15746	85.36	1387.0	1731.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
151	sp|O14965|AURKA_HU	Q96BR1	75.68	118.0	423.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
152	sp|O14965|AURKA_HU	Q9C098	76.43	319.0	627.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
153	sp|O14965|AURKA_HU	Q9NYY3	75.93	30.0	336.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
154	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB01919	Pentanal	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
155	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB01940	Balanol Analog 2	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
156	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB02155	3-[(3-sec-butyl-4-hydroxybenzoyl)amino]azepan-4-yl 4-(2-hydroxy-5-methoxybenzoyl)benzoate	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
157	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB02482	Phosphonothreonine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
158	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB02611	Balanol Analog 1	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
159	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB03374	3,5-Diiodotyrosine	experimental	DB00135	Tyrosine	approved; investigational; nutraceutical	0.71
160	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB03374	3,5-Diiodotyrosine	experimental	DB00279	Liothyronine	approved; vet_approved	0.74
161	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB03374	3,5-Diiodotyrosine	experimental	DB00451	Levothyroxine	approved	0.73
162	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB03374	3,5-Diiodotyrosine	experimental	DB00509	Dextrothyroxine	approved; investigational	0.73
163	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB03374	3,5-Diiodotyrosine	experimental	DB01583	Liotrix	approved	0.73
164	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB04098	Balanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
165	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB04522	Dexfosfoserine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
166	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB04530	S,S-(2-Hydroxyethyl)Thiocysteine	experimental	DB00138	Cystine	approved; nutraceutical	0.92
167	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB04707	Hydroxyfasudil	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
168	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB06959	(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
169	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB06977	(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
170	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07107	(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
171	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07124	(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
172	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07204	(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
173	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07235	N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
174	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07458	3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
175	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07583	(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
176	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07854	N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
177	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07855	(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
178	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07856	6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
179	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07857	(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
180	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07858	(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
181	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07859	4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
182	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07860	(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
183	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07876	(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
184	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07947	ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
185	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07995	H-89	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
186	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07996	5-(2-methylpiperazine-1-sulfonyl)isoquinoline	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
187	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB07997	N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
188	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08070	2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
189	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08073	(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
190	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08113	3-pyridin-4-yl-1H-indazole	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
191	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08114	5-benzyl-1,3-thiazol-2-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
192	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08148	1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
193	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08149	1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
194	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08150	4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
195	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08162	Fasudil	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
196	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08231	Myristic acid	experimental	DB00513	Aminocaproic acid	approved; investigational	0.76
197	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08231	Myristic acid	experimental	DB00548	Azelaic acid	approved	1.0
198	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08231	Myristic acid	experimental	DB02530	gamma-Aminobutyric acid	approved; investigational	0.72
199	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08231	Myristic acid	experimental	DB03017	Lauric acid	approved; experimental	1.0
200	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08231	Myristic acid	experimental	DB03193	Stearic acid	approved; experimental	1.0
201	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08231	Myristic acid	experimental	DB03796	Palmitic Acid	approved	1.0
202	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08231	Myristic acid	experimental	DB04224	Oleic Acid	approved; investigational; vet_approved	0.75
203	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08231	Myristic acid	experimental	DB06689	Ethanolamine oleate	approved	0.71
204	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08231	Myristic acid	experimental	DB11117	Undecylenic acid	approved; investigational	0.85
205	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08231	Myristic acid	experimental	DB15678	Calcium undecylenate	approved; experimental	0.85
206	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08568	A-674563	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
207	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08569	3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
208	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08756	Y-27632	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
209	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB08846	Ellagic acid	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
210	sp|O14965|AURKA_HU	P17612	70.72	17.0	302.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
211	sp|O14965|AURKA_HU	O75914	78.16	223.0	538.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
212	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB00163	Vitamin E	approved; nutraceutical; vet_approved	DB00163	Vitamin E	approved; nutraceutical; vet_approved	1.0
213	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB00163	Vitamin E	approved; nutraceutical; vet_approved	DB14001	alpha-Tocopherol succinate	approved; nutraceutical; vet_approved	0.88
214	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB00163	Vitamin E	approved; nutraceutical; vet_approved	DB14002	D-alpha-Tocopherol acetate	approved; nutraceutical; vet_approved	0.92
215	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB00163	Vitamin E	approved; nutraceutical; vet_approved	DB14476	DL-alpha-Tocopherol	approved; experimental; investigational	1.0
216	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB01738	Phosphorylcolamine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
217	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB06486	Enzastaurin	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
218	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB08846	Ellagic acid	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
219	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB08862	Cholecystokinin	approved; investigational	SORRY!!	Cannot find	structurally similar	approved molecules
220	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB14001	alpha-Tocopherol succinate	approved; nutraceutical; vet_approved	DB00163	Vitamin E	approved; nutraceutical; vet_approved	0.88
221	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB14001	alpha-Tocopherol succinate	approved; nutraceutical; vet_approved	DB14001	alpha-Tocopherol succinate	approved; nutraceutical; vet_approved	1.0
222	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB14001	alpha-Tocopherol succinate	approved; nutraceutical; vet_approved	DB14002	D-alpha-Tocopherol acetate	approved; nutraceutical; vet_approved	0.95
223	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB14001	alpha-Tocopherol succinate	approved; nutraceutical; vet_approved	DB14476	DL-alpha-Tocopherol	approved; experimental; investigational	0.88
224	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB14002	D-alpha-Tocopherol acetate	approved; nutraceutical; vet_approved	DB00163	Vitamin E	approved; nutraceutical; vet_approved	0.92
225	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB14002	D-alpha-Tocopherol acetate	approved; nutraceutical; vet_approved	DB14001	alpha-Tocopherol succinate	approved; nutraceutical; vet_approved	0.95
226	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB14002	D-alpha-Tocopherol acetate	approved; nutraceutical; vet_approved	DB14002	D-alpha-Tocopherol acetate	approved; nutraceutical; vet_approved	1.0
227	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB14002	D-alpha-Tocopherol acetate	approved; nutraceutical; vet_approved	DB14476	DL-alpha-Tocopherol	approved; experimental; investigational	0.92
228	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB00675	Tamoxifen	approved	DB00539	Toremifene	approved; investigational	0.94
229	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB00675	Tamoxifen	approved	DB00675	Tamoxifen	approved	1.0
230	sp|O14965|AURKA_HU	P05771	75.43	297.0	601.0	DB00675	Tamoxifen	approved	DB04938	Ospemifene	approved; investigational	0.86
231	sp|O14965|AURKA_HU	Q13153	76.43	217.0	525.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
232	sp|O14965|AURKA_HU	Q16513	73.7	620.0	917.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
233	sp|O14965|AURKA_HU	Q13177	77.92	190.0	504.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
234	sp|O14965|AURKA_HU	Q05655	75.68	300.0	605.0	DB04376	13-Acetylphorbol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
235	sp|O14965|AURKA_HU	Q05655	75.68	300.0	605.0	DB05013	Ingenol mebutate	approved	DB05013	Ingenol mebutate	approved	1.0
236	sp|O14965|AURKA_HU	Q05655	75.68	300.0	605.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
237	sp|O14965|AURKA_HU	Q05655	75.68	300.0	605.0	DB00675	Tamoxifen	approved	DB00539	Toremifene	approved; investigational	0.94
238	sp|O14965|AURKA_HU	Q05655	75.68	300.0	605.0	DB00675	Tamoxifen	approved	DB00675	Tamoxifen	approved	1.0
239	sp|O14965|AURKA_HU	Q05655	75.68	300.0	605.0	DB00675	Tamoxifen	approved	DB04938	Ospemifene	approved; investigational	0.86
240	sp|O14965|AURKA_HU	Q9UIK4	71.46	9.0	297.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
241	sp|O14965|AURKA_HU	O15075	87.59	301.0	654.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
242	sp|O14965|AURKA_HU	P41743	85.11	184.0	527.0	DB03777	Bisindolylmaleimide I	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
243	sp|O14965|AURKA_HU	P41743	85.11	184.0	527.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
244	sp|O14965|AURKA_HU	P41743	85.11	184.0	527.0	DB00675	Tamoxifen	approved	DB00539	Toremifene	approved; investigational	0.94
245	sp|O14965|AURKA_HU	P41743	85.11	184.0	527.0	DB00675	Tamoxifen	approved	DB00675	Tamoxifen	approved	1.0
246	sp|O14965|AURKA_HU	P41743	85.11	184.0	527.0	DB00675	Tamoxifen	approved	DB04938	Ospemifene	approved; investigational	0.86
247	sp|O14965|AURKA_HU	Q8N568	70.22	381.0	664.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
248	sp|O14965|AURKA_HU	Q16512	75.93	569.0	875.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
249	sp|O14965|AURKA_HU	P43403	83.87	252.0	590.0	DB02010	Staurosporine	experimental	DB00115	Cyanocobalamin	approved; nutraceutical	0.7
250	sp|O14965|AURKA_HU	P43403	83.87	252.0	590.0	DB02010	Staurosporine	experimental	DB00200	Hydroxocobalamin	approved	0.73
251	sp|O14965|AURKA_HU	P43403	83.87	252.0	590.0	DB02010	Staurosporine	experimental	DB00309	Vindesine	approved; investigational	0.71
252	sp|O14965|AURKA_HU	P43403	83.87	252.0	590.0	DB02010	Staurosporine	experimental	DB00361	Vinorelbine	approved; investigational	0.72
253	sp|O14965|AURKA_HU	P43403	83.87	252.0	590.0	DB02010	Staurosporine	experimental	DB00541	Vincristine	approved; investigational	0.71
254	sp|O14965|AURKA_HU	P43403	83.87	252.0	590.0	DB02010	Staurosporine	experimental	DB00570	Vinblastine	approved	0.71
255	sp|O14965|AURKA_HU	P43403	83.87	252.0	590.0	DB02010	Staurosporine	experimental	DB03614	Mecobalamin	approved; investigational	0.73
256	sp|O14965|AURKA_HU	P43403	83.87	252.0	590.0	DB02010	Staurosporine	experimental	DB06595	Midostaurin	approved; investigational	0.95
257	sp|O14965|AURKA_HU	P43403	83.87	252.0	590.0	DB02010	Staurosporine	experimental	DB11191	Cobamamide	approved	0.73
258	sp|O14965|AURKA_HU	P43403	83.87	252.0	590.0	DB02010	Staurosporine	experimental	DB11641	Vinflunine	approved; investigational	0.72
259	sp|O14965|AURKA_HU	P43403	83.87	252.0	590.0	DB02010	Staurosporine	experimental	DB12674	Lurbinectedin	approved; investigational	0.71
260	sp|O14965|AURKA_HU	P43403	83.87	252.0	590.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
261	sp|O14965|AURKA_HU	Q8IY84	73.7	29.0	326.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
262	sp|O14965|AURKA_HU	Q9Y2H1	85.11	42.0	385.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
263	sp|O14965|AURKA_HU	Q9H2G2	70.97	15.0	301.0	DB07664	K-00546	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
264	sp|O14965|AURKA_HU	Q9H2G2	70.97	15.0	301.0	DB07853	2-[4-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]iminocyclohexa-2,5-dien-1-yl]acetonitrile	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
265	sp|O14965|AURKA_HU	Q9H2G2	70.97	15.0	301.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
266	sp|O14965|AURKA_HU	Q15208	91.07	16.0	383.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
267	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB01888	4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
268	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02010	Staurosporine	experimental	DB00115	Cyanocobalamin	approved; nutraceutical	0.7
269	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02010	Staurosporine	experimental	DB00200	Hydroxocobalamin	approved	0.73
270	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02010	Staurosporine	experimental	DB00309	Vindesine	approved; investigational	0.71
271	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02010	Staurosporine	experimental	DB00361	Vinorelbine	approved; investigational	0.72
272	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02010	Staurosporine	experimental	DB00541	Vincristine	approved; investigational	0.71
273	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02010	Staurosporine	experimental	DB00570	Vinblastine	approved	0.71
274	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02010	Staurosporine	experimental	DB03614	Mecobalamin	approved; investigational	0.73
275	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02010	Staurosporine	experimental	DB06595	Midostaurin	approved; investigational	0.95
276	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02010	Staurosporine	experimental	DB11191	Cobamamide	approved	0.73
277	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02010	Staurosporine	experimental	DB11641	Vinflunine	approved; investigational	0.72
278	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02010	Staurosporine	experimental	DB12674	Lurbinectedin	approved; investigational	0.71
279	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02052	Indirubin-3'-monoxime	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
280	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02091	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
281	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02116	Olomoucine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
282	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02197	4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
283	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02297	2-Amino-6-Chloropyrazine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
284	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02407	6-O-Cyclohexylmethyl Guanine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
285	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02538	N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
286	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02603	1-Amino-6-Cyclohex-3-Enylmethyloxypurine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
287	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02647	N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
288	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02733	Purvalanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
289	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02833	[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
290	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02898	(5R)-5-{[(2-Amino-3H-purin-6-yl)oxy]methyl}-2-pyrrolidinone	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
291	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02915	4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
292	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02950	Hymenialdisine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
293	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02963	(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
294	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB02973	4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
295	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03019	4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
296	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03307	4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
297	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03365	4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline	experimental	DB00317	Gefitinib	approved; investigational	0.75
298	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03365	4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline	experimental	DB00530	Erlotinib	approved; investigational	0.81
299	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03365	4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline	experimental	DB05294	Vandetanib	approved	0.72
300	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03428	SU9516	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
301	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03490	3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
302	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03496	Alvocidib	experimental; investigational	SORRY!!	Cannot find	structurally similar	approved molecules
303	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03583	(2E,3S)-3-hydroxy-5'-[(4-hydroxypiperidin-1-yl)sulfonyl]-3-methyl-1,3-dihydro-2,3'-biindol-2'(1'H)-one	experimental	DB00200	Hydroxocobalamin	approved	0.72
304	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03583	(2E,3S)-3-hydroxy-5'-[(4-hydroxypiperidin-1-yl)sulfonyl]-3-methyl-1,3-dihydro-2,3'-biindol-2'(1'H)-one	experimental	DB00309	Vindesine	approved; investigational	0.71
305	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03583	(2E,3S)-3-hydroxy-5'-[(4-hydroxypiperidin-1-yl)sulfonyl]-3-methyl-1,3-dihydro-2,3'-biindol-2'(1'H)-one	experimental	DB00361	Vinorelbine	approved; investigational	0.72
306	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03583	(2E,3S)-3-hydroxy-5'-[(4-hydroxypiperidin-1-yl)sulfonyl]-3-methyl-1,3-dihydro-2,3'-biindol-2'(1'H)-one	experimental	DB00541	Vincristine	approved; investigational	0.72
307	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03583	(2E,3S)-3-hydroxy-5'-[(4-hydroxypiperidin-1-yl)sulfonyl]-3-methyl-1,3-dihydro-2,3'-biindol-2'(1'H)-one	experimental	DB00570	Vinblastine	approved	0.71
308	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03583	(2E,3S)-3-hydroxy-5'-[(4-hydroxypiperidin-1-yl)sulfonyl]-3-methyl-1,3-dihydro-2,3'-biindol-2'(1'H)-one	experimental	DB03614	Mecobalamin	approved; investigational	0.72
309	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03583	(2E,3S)-3-hydroxy-5'-[(4-hydroxypiperidin-1-yl)sulfonyl]-3-methyl-1,3-dihydro-2,3'-biindol-2'(1'H)-one	experimental	DB11191	Cobamamide	approved	0.73
310	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03583	(2E,3S)-3-hydroxy-5'-[(4-hydroxypiperidin-1-yl)sulfonyl]-3-methyl-1,3-dihydro-2,3'-biindol-2'(1'H)-one	experimental	DB11641	Vinflunine	approved; investigational	0.72
311	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03583	(2E,3S)-3-hydroxy-5'-[(4-hydroxypiperidin-1-yl)sulfonyl]-3-methyl-1,3-dihydro-2,3'-biindol-2'(1'H)-one	experimental	DB12674	Lurbinectedin	approved; investigational	0.71
312	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03663	1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
313	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03737	4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
314	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03801	Lysine Nz-Carboxylic Acid	experimental	DB00123	L-Lysine	approved; nutraceutical	0.73
315	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB03801	Lysine Nz-Carboxylic Acid	experimental	DB12839	Pegvaliase	approved; investigational	0.73
316	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB04006	[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
317	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB04101	N'-[4-(2,4-Dimethyl-1,3-thiazol-5-yl)-2-pyrimidinyl]-N-hydroxyimidoformamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
318	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB04186	N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
319	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB04288	2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine	experimental	DB01048	Abacavir	approved; investigational	0.73
320	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB04407	4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
321	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB04518	3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
322	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB04607	PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
323	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB04662	OLOMOUCINE II	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
324	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB04669	TRIAZOLOPYRIMIDINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
325	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB06195	Seliciclib	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
326	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB06616	Bosutinib	approved	DB06616	Bosutinib	approved	1.0
327	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB06844	4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
328	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB06888	(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
329	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB06944	N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
330	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB06948	2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
331	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB06976	1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
332	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB06983	(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
333	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07024	2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
334	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07054	(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
335	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07065	5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
336	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07126	O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
337	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07137	(2S)-N-[(3E)-5-Cyclopropyl-3H-pyrazol-3-ylidene]-2-[4-(2-oxo-1-imidazolidinyl)phenyl]propanamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
338	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07163	5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
339	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07164	N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
340	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07179	3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
341	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07203	6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
342	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07210	3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
343	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07220	N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
344	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07431	(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
345	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07471	5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
346	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07493	5-Bromoindirubin	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
347	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07501	(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
348	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07504	(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
349	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07529	(5E)-2-Amino-5-(2-pyridinylmethylene)-1,3-thiazol-4(5H)-one	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
350	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07531	4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
351	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07533	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
352	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07534	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
353	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07538	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
354	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07539	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
355	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07540	4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
356	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07562	N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
357	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07595	(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
358	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07606	6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
359	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07612	6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
360	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07618	2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
361	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07622	1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA	experimental	DB00200	Hydroxocobalamin	approved	0.74
362	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07622	1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA	experimental	DB00309	Vindesine	approved; investigational	0.72
363	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07622	1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA	experimental	DB00361	Vinorelbine	approved; investigational	0.73
364	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07622	1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA	experimental	DB00541	Vincristine	approved; investigational	0.73
365	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07622	1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA	experimental	DB00570	Vinblastine	approved	0.73
366	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07622	1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA	experimental	DB03614	Mecobalamin	approved; investigational	0.74
367	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07622	1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA	experimental	DB11191	Cobamamide	approved	0.74
368	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07622	1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA	experimental	DB11641	Vinflunine	approved; investigational	0.73
369	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07622	1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA	experimental	DB12674	Lurbinectedin	approved; investigational	0.72
370	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07685	4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
371	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07686	4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
372	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07687	4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
373	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07688	4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
374	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07731	CAN-508	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
375	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07750	(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
376	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07751	(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
377	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07755	(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
378	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07761	(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
379	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07790	N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
380	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07791	4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
381	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07852	1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
382	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07889	(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
383	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07936	N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
384	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB07982	2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
385	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08066	N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
386	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08094	RO-4584820	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
387	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08122	N-Methyl-4-{[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}benzenesulfonamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
388	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08123	N-methyl-{4-[2-(7-oxo-6,7-dihydro-8H-[1,3]thiazolo[5,4-e]indol-8-ylidene)hydrazino]phenyl}methanesulfonamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
389	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08124	3-{[(2,2-dioxido-1,3-dihydro-2-benzothien-5-yl)amino]methylene}-5-(1,3-oxazol-5-yl)-1,3-dihydro-2H-indol-2-one	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
390	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08125	4-{[(2-Oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}-N-(1,3-thiazol-2-yl)benzenesulfonamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
391	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08126	3-{[4-([amino(imino)methyl]aminosulfonyl)anilino]methylene}-2-oxo-2,3-dihydro-1H-indole	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
392	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08132	5-hydroxynaphthalene-1-sulfonamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
393	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08133	N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
394	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08134	4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
395	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08135	N-phenyl-1H-pyrazole-3-carboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
396	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08136	4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
397	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08137	(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
398	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08138	{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
399	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08139	5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
400	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08140	5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
401	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08141	4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
402	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08142	AT-7519	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
403	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08178	4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
404	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08182	4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
405	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08218	HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
406	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08219	4-Methyl-5-[(2Z)-2-{[4-(4-morpholinyl)phenyl]imino}-2,5-dihydro-4-pyrimidinyl]-1,3-thiazol-2-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
407	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08233	6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
408	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08241	4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
409	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08247	6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
410	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08248	3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
411	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08285	(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
412	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08309	3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
413	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08312	6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
414	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08355	1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
415	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08441	6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
416	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08463	(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
417	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08527	1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
418	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08531	5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
419	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08532	6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
420	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08533	3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
421	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08534	5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
422	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08535	3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
423	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08536	3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
424	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08537	3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
425	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08538	N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
426	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08539	3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
427	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08572	4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
428	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08673	4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
429	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08677	N-(5-Isopropyl-thiazol-2-YL)-2-pyridin-3-YL-acetamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
430	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08694	Variolin B	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
431	sp|O14965|AURKA_HU	P24941	71.46	2.0	290.0	DB08768	N(6)-dimethylallyladenine	experimental	DB00173	Adenine	approved; nutraceutical	0.73
432	NIL	NIL	NIL	NIL	NIL	NIL	NIL	NIL	SORRY!!	Cannot find	structurally similar	approved molecules
433	sp|O14965|AURKA_HU	Q05397	74.69	390.0	691.0	DB07248	7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
434	sp|O14965|AURKA_HU	Q05397	74.69	390.0	691.0	DB07460	2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
435	sp|O14965|AURKA_HU	Q05397	74.69	390.0	691.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
436	sp|O14965|AURKA_HU	O95747	71.96	9.0	299.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
437	sp|O14965|AURKA_HU	Q05513	83.62	182.0	519.0	DB00675	Tamoxifen	approved	DB00539	Toremifene	approved; investigational	0.94
438	sp|O14965|AURKA_HU	Q05513	83.62	182.0	519.0	DB00675	Tamoxifen	approved	DB00675	Tamoxifen	approved	1.0
439	sp|O14965|AURKA_HU	Q05513	83.62	182.0	519.0	DB00675	Tamoxifen	approved	DB04938	Ospemifene	approved; investigational	0.86
440	sp|O14965|AURKA_HU	Q99759	70.47	339.0	623.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
441	sp|O14965|AURKA_HU	Q13464	70.72	59.0	344.0	DB04707	Hydroxyfasudil	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
442	sp|O14965|AURKA_HU	Q13464	70.72	59.0	344.0	DB07876	(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
443	sp|O14965|AURKA_HU	Q13464	70.72	59.0	344.0	DB08162	Fasudil	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
444	sp|O14965|AURKA_HU	Q13464	70.72	59.0	344.0	DB08756	Y-27632	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
445	sp|O14965|AURKA_HU	Q13464	70.72	59.0	344.0	DB13165	Ripasudil	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
446	sp|O14965|AURKA_HU	Q13464	70.72	59.0	344.0	DB13931	Netarsudil	approved	DB13931	Netarsudil	approved	1.0
447	sp|O14965|AURKA_HU	Q9BXA7	70.47	7.0	291.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
448	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB00398	Sorafenib	approved; investigational	DB00398	Sorafenib	approved; investigational	1.0
449	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB00398	Sorafenib	approved; investigational	DB08896	Regorafenib	approved	0.87
450	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB01109	Heparin	approved; investigational	DB00398	Sorafenib	approved; investigational	1.0
451	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB01109	Heparin	approved; investigational	DB08896	Regorafenib	approved	0.87
452	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB02058	3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
453	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB05014	XL999	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
454	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB07525	3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
455	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB07840	(E)-[4-(3,5-Difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
456	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB08577	3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
457	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB08896	Regorafenib	approved	DB00398	Sorafenib	approved; investigational	0.87
458	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB08896	Regorafenib	approved	DB08896	Regorafenib	approved	1.0
459	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB08901	Ponatinib	approved; investigational	DB08901	Ponatinib	approved; investigational	1.0
460	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB09078	Lenvatinib	approved; investigational	DB09078	Lenvatinib	approved; investigational	1.0
461	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB09079	Nintedanib	approved	DB09079	Nintedanib	approved	1.0
462	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
463	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB12147	Erdafitinib	approved; investigational	DB12147	Erdafitinib	approved; investigational	1.0
464	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB15102	Pemigatinib	approved; investigational	DB00200	Hydroxocobalamin	approved	0.7
465	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB15102	Pemigatinib	approved; investigational	DB03614	Mecobalamin	approved; investigational	0.7
466	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB15102	Pemigatinib	approved; investigational	DB11191	Cobamamide	approved	0.71
467	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB15102	Pemigatinib	approved; investigational	DB15102	Pemigatinib	approved; investigational	1.0
468	sp|O14965|AURKA_HU	P11362	74.94	450.0	752.0	DB15685	Selpercatinib	approved; investigational	DB15685	Selpercatinib	approved; investigational	1.0
469	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB01041	Thalidomide	approved; investigational; withdrawn	DB00480	Lenalidomide	approved	0.81
470	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB01041	Thalidomide	approved; investigational; withdrawn	DB01041	Thalidomide	approved; investigational; withdrawn	1.0
471	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB01041	Thalidomide	approved; investigational; withdrawn	DB08910	Pomalidomide	approved	0.82
472	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB01109	Heparin	approved; investigational	DB00480	Lenalidomide	approved	0.81
473	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB01109	Heparin	approved; investigational	DB01041	Thalidomide	approved; investigational; withdrawn	1.0
474	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB01109	Heparin	approved; investigational	DB08910	Pomalidomide	approved	0.82
475	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB01901	Sucrosofate	experimental	DB00364	Sucralfate	approved	0.92
476	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB01901	Sucrosofate	experimental	DB00686	Pentosan polysulfate	approved	0.81
477	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB02058	3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
478	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB02491	4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
479	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB08896	Regorafenib	approved	DB00398	Sorafenib	approved; investigational	0.87
480	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB08896	Regorafenib	approved	DB08896	Regorafenib	approved	1.0
481	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB08901	Ponatinib	approved; investigational	DB08901	Ponatinib	approved; investigational	1.0
482	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB09078	Lenvatinib	approved; investigational	DB09078	Lenvatinib	approved; investigational	1.0
483	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB09079	Nintedanib	approved	DB09079	Nintedanib	approved	1.0
484	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
485	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB12147	Erdafitinib	approved; investigational	DB12147	Erdafitinib	approved; investigational	1.0
486	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB15102	Pemigatinib	approved; investigational	DB00200	Hydroxocobalamin	approved	0.7
487	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB15102	Pemigatinib	approved; investigational	DB03614	Mecobalamin	approved; investigational	0.7
488	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB15102	Pemigatinib	approved; investigational	DB11191	Cobamamide	approved	0.71
489	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB15102	Pemigatinib	approved; investigational	DB15102	Pemigatinib	approved; investigational	1.0
490	sp|O14965|AURKA_HU	P21802	80.89	429.0	755.0	DB15685	Selpercatinib	approved; investigational	DB15685	Selpercatinib	approved; investigational	1.0
491	sp|O14965|AURKA_HU	O75116	70.22	83.0	366.0	DB08162	Fasudil	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
492	sp|O14965|AURKA_HU	O75116	70.22	83.0	366.0	DB08756	Y-27632	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
493	sp|O14965|AURKA_HU	O75116	70.22	83.0	366.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
494	sp|O14965|AURKA_HU	O75116	70.22	83.0	366.0	DB13165	Ripasudil	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
495	sp|O14965|AURKA_HU	O75116	70.22	83.0	366.0	DB13931	Netarsudil	approved	DB13931	Netarsudil	approved	1.0
496	sp|O14965|AURKA_HU	Q96RR4	78.16	140.0	455.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
497	sp|O14965|AURKA_HU	Q00532	73.7	3.0	300.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
498	sp|O14965|AURKA_HU	Q92772	72.46	2.0	294.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
499	sp|O14965|AURKA_HU	Q56UN5	72.46	1034.0	1326.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
500	sp|O14965|AURKA_HU	Q13233	88.09	1154.0	1509.0	DB06061	AZD-8330	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
501	sp|O14965|AURKA_HU	Q13233	88.09	1154.0	1509.0	DB11967	Binimetinib	approved; investigational	DB11689	Selumetinib	approved; investigational	0.93
502	sp|O14965|AURKA_HU	Q13233	88.09	1154.0	1509.0	DB11967	Binimetinib	approved; investigational	DB11967	Binimetinib	approved; investigational	1.0
503	sp|O14965|AURKA_HU	Q13233	88.09	1154.0	1509.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
504	sp|O14965|AURKA_HU	Q07785	70.72	2.0	287.0	DB02519	Indirubin-5-sulphonate	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
505	sp|O14965|AURKA_HU	Q07785	70.72	2.0	287.0	DB02733	Purvalanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
506	sp|O14965|AURKA_HU	Q9Y2H9	75.68	345.0	650.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
507	sp|O14965|AURKA_HU	Q9UPZ9	74.19	2.0	301.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
508	sp|O14965|AURKA_HU	P06493	72.46	2.0	294.0	DB02052	Indirubin-3'-monoxime	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
509	sp|O14965|AURKA_HU	P06493	72.46	2.0	294.0	DB02116	Olomoucine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
510	sp|O14965|AURKA_HU	P06493	72.46	2.0	294.0	DB02950	Hymenialdisine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
511	sp|O14965|AURKA_HU	P06493	72.46	2.0	294.0	DB03428	SU9516	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
512	sp|O14965|AURKA_HU	P06493	72.46	2.0	294.0	DB03496	Alvocidib	experimental; investigational	SORRY!!	Cannot find	structurally similar	approved molecules
513	sp|O14965|AURKA_HU	P06493	72.46	2.0	294.0	DB04014	Alsterpaullone	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
514	sp|O14965|AURKA_HU	P06493	72.46	2.0	294.0	DB06195	Seliciclib	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
515	sp|O14965|AURKA_HU	P06493	72.46	2.0	294.0	DB08142	AT-7519	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
516	sp|O14965|AURKA_HU	P06493	72.46	2.0	294.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
517	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00115	Cyanocobalamin	approved; nutraceutical	0.74
518	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00200	Hydroxocobalamin	approved	0.8
519	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00254	Doxycycline	approved; investigational; vet_approved	0.91
520	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00256	Lymecycline	approved; investigational	0.89
521	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00290	Bleomycin	approved; investigational	0.73
522	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00309	Vindesine	approved; investigational	0.78
523	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00361	Vinorelbine	approved; investigational	0.79
524	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00512	Vancomycin	approved	0.71
525	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00541	Vincristine	approved; investigational	0.78
526	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00560	Tigecycline	approved	0.96
527	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00570	Vinblastine	approved	0.78
528	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00595	Oxytetracycline	approved; investigational; vet_approved	0.89
529	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00615	Rifabutin	approved; investigational	0.74
530	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00618	Demeclocycline	approved	0.9
531	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00696	Ergotamine	approved	0.71
532	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00759	Tetracycline	approved; vet_approved	0.9
533	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00762	Irinotecan	approved; investigational	0.71
534	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00931	Metacycline	approved; investigational	0.89
535	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB00970	Dactinomycin	approved; investigational	0.73
536	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB01017	Minocycline	approved; investigational	1.0
537	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB01200	Bromocriptine	approved; investigational	0.72
538	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB01220	Rifaximin	approved; investigational	0.72
539	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB01301	Rolitetracycline	approved	0.89
540	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB01452	Diamorphine	approved; illicit; investigational	0.71
541	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB03614	Mecobalamin	approved; investigational	0.8
542	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB04865	Omacetaxine mepesuccinate	approved; investigational	0.7
543	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB04911	Oritavancin	approved; investigational	0.73
544	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB05109	Trabectedin	approved; investigational	0.75
545	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB06402	Telavancin	approved	0.73
546	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.89
547	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB11191	Cobamamide	approved	0.8
548	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB11641	Vinflunine	approved; investigational	0.79
549	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB11691	Naldemedine	approved; investigational	0.77
550	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB12035	Sarecycline	approved; investigational	0.91
551	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB12329	Eravacycline	approved; investigational	0.92
552	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB12455	Omadacycline	approved; investigational	0.96
553	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB12674	Lurbinectedin	approved; investigational	0.77
554	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB13345	Dihydroergocristine	approved; experimental	0.7
555	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB13997	Baloxavir marboxil	approved; investigational	0.71
556	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01017	Minocycline	approved; investigational	DB15465	Benzhydrocodone	approved	0.7
557	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB15624	Halicin	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
558	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB01782	Pyrazolanthrone	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
559	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB02388	Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
560	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB03084	Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
561	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB03623	9-(4-Hydroxyphenyl)-2,7-Phenanthroline	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
562	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00118	Ademetionine	approved; investigational; nutraceutical	0.76
563	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00131	Adenosine phosphate	approved; investigational; nutraceutical	0.88
564	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00157	NADH	approved; nutraceutical	0.8
565	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00194	Vidarabine	approved; investigational	0.82
566	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00242	Cladribine	approved; investigational	0.72
567	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00640	Adenosine	approved; investigational	0.82
568	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB01073	Fludarabine	approved	0.79
569	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB01280	Nelarabine	approved; investigational	0.71
570	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB03147	Flavin adenine dinucleotide	approved	0.73
571	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB05528	Mipomersen	approved; investigational	0.71
572	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB06213	Regadenoson	approved; investigational	0.75
573	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB06441	Cangrelor	approved	0.78
574	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB06933	N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
575	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB07010	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
576	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB07217	N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
577	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB08005	4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
578	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB08010	(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
579	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB08011	(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
580	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB08015	(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
581	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB08021	5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
582	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB08023	N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
583	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB08025	N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
584	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB08026	2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
585	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB08555	1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
586	sp|O14965|AURKA_HU	P53779	76.43	52.0	360.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
587	sp|O14965|AURKA_HU	Q9UEW8	71.46	56.0	344.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
588	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB00675	Tamoxifen	approved	DB00539	Toremifene	approved; investigational	0.94
589	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB00675	Tamoxifen	approved	DB00675	Tamoxifen	approved	1.0
590	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB00675	Tamoxifen	approved	DB04938	Ospemifene	approved; investigational	0.86
591	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01782	Pyrazolanthrone	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
592	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB07218	6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
593	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB07268	2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
594	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB07272	N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
595	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB07276	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
596	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB07845	2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
597	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00115	Cyanocobalamin	approved; nutraceutical	0.74
598	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00200	Hydroxocobalamin	approved	0.8
599	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00254	Doxycycline	approved; investigational; vet_approved	0.91
600	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00256	Lymecycline	approved; investigational	0.89
601	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00290	Bleomycin	approved; investigational	0.73
602	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00309	Vindesine	approved; investigational	0.78
603	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00361	Vinorelbine	approved; investigational	0.79
604	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00512	Vancomycin	approved	0.71
605	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00541	Vincristine	approved; investigational	0.78
606	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00560	Tigecycline	approved	0.96
607	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00570	Vinblastine	approved	0.78
608	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00595	Oxytetracycline	approved; investigational; vet_approved	0.89
609	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00615	Rifabutin	approved; investigational	0.74
610	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00618	Demeclocycline	approved	0.9
611	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00696	Ergotamine	approved	0.71
612	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00759	Tetracycline	approved; vet_approved	0.9
613	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00762	Irinotecan	approved; investigational	0.71
614	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00931	Metacycline	approved; investigational	0.89
615	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB00970	Dactinomycin	approved; investigational	0.73
616	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB01017	Minocycline	approved; investigational	1.0
617	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB01200	Bromocriptine	approved; investigational	0.72
618	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB01220	Rifaximin	approved; investigational	0.72
619	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB01301	Rolitetracycline	approved	0.89
620	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB01452	Diamorphine	approved; illicit; investigational	0.71
621	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB03614	Mecobalamin	approved; investigational	0.8
622	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB04865	Omacetaxine mepesuccinate	approved; investigational	0.7
623	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB04911	Oritavancin	approved; investigational	0.73
624	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB05109	Trabectedin	approved; investigational	0.75
625	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB06402	Telavancin	approved	0.73
626	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.89
627	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB11191	Cobamamide	approved	0.8
628	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB11641	Vinflunine	approved; investigational	0.79
629	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB11691	Naldemedine	approved; investigational	0.77
630	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB12035	Sarecycline	approved; investigational	0.91
631	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB12329	Eravacycline	approved; investigational	0.92
632	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB12455	Omadacycline	approved; investigational	0.96
633	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB12674	Lurbinectedin	approved; investigational	0.77
634	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB13345	Dihydroergocristine	approved; experimental	0.7
635	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB13997	Baloxavir marboxil	approved; investigational	0.71
636	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB01017	Minocycline	approved; investigational	DB15465	Benzhydrocodone	approved	0.7
637	sp|O14965|AURKA_HU	P45983	75.19	20.0	323.0	DB15624	Halicin	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
638	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00115	Cyanocobalamin	approved; nutraceutical	0.74
639	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00200	Hydroxocobalamin	approved	0.8
640	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00254	Doxycycline	approved; investigational; vet_approved	0.91
641	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00256	Lymecycline	approved; investigational	0.89
642	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00290	Bleomycin	approved; investigational	0.73
643	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00309	Vindesine	approved; investigational	0.78
644	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00361	Vinorelbine	approved; investigational	0.79
645	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00512	Vancomycin	approved	0.71
646	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00541	Vincristine	approved; investigational	0.78
647	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00560	Tigecycline	approved	0.96
648	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00570	Vinblastine	approved	0.78
649	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00595	Oxytetracycline	approved; investigational; vet_approved	0.89
650	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00615	Rifabutin	approved; investigational	0.74
651	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00618	Demeclocycline	approved	0.9
652	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00696	Ergotamine	approved	0.71
653	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00759	Tetracycline	approved; vet_approved	0.9
654	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00762	Irinotecan	approved; investigational	0.71
655	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00931	Metacycline	approved; investigational	0.89
656	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB00970	Dactinomycin	approved; investigational	0.73
657	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB01017	Minocycline	approved; investigational	1.0
658	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB01200	Bromocriptine	approved; investigational	0.72
659	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB01220	Rifaximin	approved; investigational	0.72
660	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB01301	Rolitetracycline	approved	0.89
661	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB01452	Diamorphine	approved; illicit; investigational	0.71
662	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB03614	Mecobalamin	approved; investigational	0.8
663	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB04865	Omacetaxine mepesuccinate	approved; investigational	0.7
664	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB04911	Oritavancin	approved; investigational	0.73
665	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB05109	Trabectedin	approved; investigational	0.75
666	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB06402	Telavancin	approved	0.73
667	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.89
668	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB11191	Cobamamide	approved	0.8
669	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB11641	Vinflunine	approved; investigational	0.79
670	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB11691	Naldemedine	approved; investigational	0.77
671	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB12035	Sarecycline	approved; investigational	0.91
672	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB12329	Eravacycline	approved; investigational	0.92
673	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB12455	Omadacycline	approved; investigational	0.96
674	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB12674	Lurbinectedin	approved; investigational	0.77
675	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB13345	Dihydroergocristine	approved; experimental	0.7
676	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB13997	Baloxavir marboxil	approved; investigational	0.71
677	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB01017	Minocycline	approved; investigational	DB15465	Benzhydrocodone	approved	0.7
678	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB02482	Phosphonothreonine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
679	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00118	Ademetionine	approved; investigational; nutraceutical	0.76
680	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00131	Adenosine phosphate	approved; investigational; nutraceutical	0.88
681	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00157	NADH	approved; nutraceutical	0.8
682	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00194	Vidarabine	approved; investigational	0.82
683	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00242	Cladribine	approved; investigational	0.72
684	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00640	Adenosine	approved; investigational	0.82
685	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB01073	Fludarabine	approved	0.79
686	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB01280	Nelarabine	approved; investigational	0.71
687	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB03147	Flavin adenine dinucleotide	approved	0.73
688	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB05528	Mipomersen	approved; investigational	0.71
689	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB06213	Regadenoson	approved; investigational	0.75
690	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB06441	Cangrelor	approved	0.78
691	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05157	KC706	investigational	DB00118	Ademetionine	approved; investigational; nutraceutical	0.76
692	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05157	KC706	investigational	DB00131	Adenosine phosphate	approved; investigational; nutraceutical	0.88
693	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05157	KC706	investigational	DB00157	NADH	approved; nutraceutical	0.8
694	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05157	KC706	investigational	DB00194	Vidarabine	approved; investigational	0.82
695	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05157	KC706	investigational	DB00242	Cladribine	approved; investigational	0.72
696	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05157	KC706	investigational	DB00640	Adenosine	approved; investigational	0.82
697	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05157	KC706	investigational	DB01073	Fludarabine	approved	0.79
698	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05157	KC706	investigational	DB01280	Nelarabine	approved; investigational	0.71
699	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05157	KC706	investigational	DB03147	Flavin adenine dinucleotide	approved	0.73
700	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05157	KC706	investigational	DB05528	Mipomersen	approved; investigational	0.71
701	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05157	KC706	investigational	DB06213	Regadenoson	approved; investigational	0.75
702	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05157	KC706	investigational	DB06441	Cangrelor	approved	0.78
703	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05403	CEP-1347	investigational	DB00115	Cyanocobalamin	approved; nutraceutical	0.7
704	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05403	CEP-1347	investigational	DB00200	Hydroxocobalamin	approved	0.73
705	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05403	CEP-1347	investigational	DB00309	Vindesine	approved; investigational	0.72
706	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05403	CEP-1347	investigational	DB00361	Vinorelbine	approved; investigational	0.73
707	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05403	CEP-1347	investigational	DB00541	Vincristine	approved; investigational	0.73
708	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05403	CEP-1347	investigational	DB00570	Vinblastine	approved	0.73
709	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05403	CEP-1347	investigational	DB03614	Mecobalamin	approved; investigational	0.73
710	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05403	CEP-1347	investigational	DB06595	Midostaurin	approved; investigational	0.79
711	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05403	CEP-1347	investigational	DB11191	Cobamamide	approved	0.73
712	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05403	CEP-1347	investigational	DB11641	Vinflunine	approved; investigational	0.73
713	sp|O14965|AURKA_HU	P53778	76.18	15.0	322.0	DB05403	CEP-1347	investigational	DB12674	Lurbinectedin	approved; investigational	0.71
714	sp|O14965|AURKA_HU	Q9UF33	75.93	621.0	927.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
715	sp|O14965|AURKA_HU	Q8N5S9	77.42	108.0	420.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
716	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB07020	N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
717	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
718	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00115	Cyanocobalamin	approved; nutraceutical	0.74
719	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00200	Hydroxocobalamin	approved	0.8
720	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00254	Doxycycline	approved; investigational; vet_approved	0.91
721	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00256	Lymecycline	approved; investigational	0.89
722	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00290	Bleomycin	approved; investigational	0.73
723	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00309	Vindesine	approved; investigational	0.78
724	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00361	Vinorelbine	approved; investigational	0.79
725	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00512	Vancomycin	approved	0.71
726	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00541	Vincristine	approved; investigational	0.78
727	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00560	Tigecycline	approved	0.96
728	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00570	Vinblastine	approved	0.78
729	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00595	Oxytetracycline	approved; investigational; vet_approved	0.89
730	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00615	Rifabutin	approved; investigational	0.74
731	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00618	Demeclocycline	approved	0.9
732	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00696	Ergotamine	approved	0.71
733	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00759	Tetracycline	approved; vet_approved	0.9
734	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00762	Irinotecan	approved; investigational	0.71
735	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00931	Metacycline	approved; investigational	0.89
736	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB00970	Dactinomycin	approved; investigational	0.73
737	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB01017	Minocycline	approved; investigational	1.0
738	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB01200	Bromocriptine	approved; investigational	0.72
739	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB01220	Rifaximin	approved; investigational	0.72
740	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB01301	Rolitetracycline	approved	0.89
741	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB01452	Diamorphine	approved; illicit; investigational	0.71
742	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB03614	Mecobalamin	approved; investigational	0.8
743	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB04865	Omacetaxine mepesuccinate	approved; investigational	0.7
744	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB04911	Oritavancin	approved; investigational	0.73
745	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB05109	Trabectedin	approved; investigational	0.75
746	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB06402	Telavancin	approved	0.73
747	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.89
748	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB11191	Cobamamide	approved	0.8
749	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB11641	Vinflunine	approved; investigational	0.79
750	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB11691	Naldemedine	approved; investigational	0.77
751	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB12035	Sarecycline	approved; investigational	0.91
752	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB12329	Eravacycline	approved; investigational	0.92
753	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB12455	Omadacycline	approved; investigational	0.96
754	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB12674	Lurbinectedin	approved; investigational	0.77
755	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB13345	Dihydroergocristine	approved; experimental	0.7
756	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB13997	Baloxavir marboxil	approved; investigational	0.71
757	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB01017	Minocycline	approved; investigational	DB15465	Benzhydrocodone	approved	0.7
758	sp|O14965|AURKA_HU	P45984	75.43	19.0	323.0	DB15624	Halicin	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
759	sp|O14965|AURKA_HU	P49137	74.69	33.0	334.0	DB02010	Staurosporine	experimental	DB00115	Cyanocobalamin	approved; nutraceutical	0.7
760	sp|O14965|AURKA_HU	P49137	74.69	33.0	334.0	DB02010	Staurosporine	experimental	DB00200	Hydroxocobalamin	approved	0.73
761	sp|O14965|AURKA_HU	P49137	74.69	33.0	334.0	DB02010	Staurosporine	experimental	DB00309	Vindesine	approved; investigational	0.71
762	sp|O14965|AURKA_HU	P49137	74.69	33.0	334.0	DB02010	Staurosporine	experimental	DB00361	Vinorelbine	approved; investigational	0.72
763	sp|O14965|AURKA_HU	P49137	74.69	33.0	334.0	DB02010	Staurosporine	experimental	DB00541	Vincristine	approved; investigational	0.71
764	sp|O14965|AURKA_HU	P49137	74.69	33.0	334.0	DB02010	Staurosporine	experimental	DB00570	Vinblastine	approved	0.71
765	sp|O14965|AURKA_HU	P49137	74.69	33.0	334.0	DB02010	Staurosporine	experimental	DB03614	Mecobalamin	approved; investigational	0.73
766	sp|O14965|AURKA_HU	P49137	74.69	33.0	334.0	DB02010	Staurosporine	experimental	DB06595	Midostaurin	approved; investigational	0.95
767	sp|O14965|AURKA_HU	P49137	74.69	33.0	334.0	DB02010	Staurosporine	experimental	DB11191	Cobamamide	approved	0.73
768	sp|O14965|AURKA_HU	P49137	74.69	33.0	334.0	DB02010	Staurosporine	experimental	DB11641	Vinflunine	approved; investigational	0.72
769	sp|O14965|AURKA_HU	P49137	74.69	33.0	334.0	DB02010	Staurosporine	experimental	DB12674	Lurbinectedin	approved; investigational	0.71
770	sp|O14965|AURKA_HU	P49137	74.69	33.0	334.0	DB07234	3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
771	sp|O14965|AURKA_HU	P49137	74.69	33.0	334.0	DB07406	(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
772	sp|O14965|AURKA_HU	P49137	74.69	33.0	334.0	DB07430	(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
773	sp|O14965|AURKA_HU	P49137	74.69	33.0	334.0	DB07431	(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
774	sp|O14965|AURKA_HU	P49137	74.69	33.0	334.0	DB07728	2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
775	sp|O14965|AURKA_HU	P49137	74.69	33.0	334.0	DB08358	2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
776	sp|O14965|AURKA_HU	Q00535	70.72	2.0	287.0	DB02052	Indirubin-3'-monoxime	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
777	sp|O14965|AURKA_HU	Q00535	70.72	2.0	287.0	DB02116	Olomoucine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
778	sp|O14965|AURKA_HU	Q00535	70.72	2.0	287.0	DB02950	Hymenialdisine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
779	sp|O14965|AURKA_HU	Q00535	70.72	2.0	287.0	DB03428	SU9516	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
780	sp|O14965|AURKA_HU	Q00535	70.72	2.0	287.0	DB03496	Alvocidib	experimental; investigational	SORRY!!	Cannot find	structurally similar	approved molecules
781	sp|O14965|AURKA_HU	Q00535	70.72	2.0	287.0	DB04014	Alsterpaullone	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
782	sp|O14965|AURKA_HU	Q00535	70.72	2.0	287.0	DB07364	6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
783	sp|O14965|AURKA_HU	Q16288	73.2	527.0	822.0	DB11986	Entrectinib	approved; investigational	DB11986	Entrectinib	approved; investigational	1.0
784	sp|O14965|AURKA_HU	Q16288	73.2	527.0	822.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
785	sp|O14965|AURKA_HU	Q16288	73.2	527.0	822.0	DB14723	Larotrectinib	approved; investigational	DB14723	Larotrectinib	approved; investigational	1.0
786	sp|O14965|AURKA_HU	P22607	71.46	458.0	746.0	DB05014	XL999	investigational	DB14723	Larotrectinib	approved; investigational	1.0
787	sp|O14965|AURKA_HU	P22607	71.46	458.0	746.0	DB06589	Pazopanib	approved	DB06589	Pazopanib	approved	1.0
788	sp|O14965|AURKA_HU	P22607	71.46	458.0	746.0	DB08901	Ponatinib	approved; investigational	DB08901	Ponatinib	approved; investigational	1.0
789	sp|O14965|AURKA_HU	P22607	71.46	458.0	746.0	DB09078	Lenvatinib	approved; investigational	DB09078	Lenvatinib	approved; investigational	1.0
790	sp|O14965|AURKA_HU	P22607	71.46	458.0	746.0	DB09079	Nintedanib	approved	DB09079	Nintedanib	approved	1.0
791	sp|O14965|AURKA_HU	P22607	71.46	458.0	746.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
792	sp|O14965|AURKA_HU	P22607	71.46	458.0	746.0	DB12147	Erdafitinib	approved; investigational	DB12147	Erdafitinib	approved; investigational	1.0
793	sp|O14965|AURKA_HU	P22607	71.46	458.0	746.0	DB15102	Pemigatinib	approved; investigational	DB00200	Hydroxocobalamin	approved	0.7
794	sp|O14965|AURKA_HU	P22607	71.46	458.0	746.0	DB15102	Pemigatinib	approved; investigational	DB03614	Mecobalamin	approved; investigational	0.7
795	sp|O14965|AURKA_HU	P22607	71.46	458.0	746.0	DB15102	Pemigatinib	approved; investigational	DB11191	Cobamamide	approved	0.71
796	sp|O14965|AURKA_HU	P22607	71.46	458.0	746.0	DB15102	Pemigatinib	approved; investigational	DB15102	Pemigatinib	approved; investigational	1.0
797	sp|O14965|AURKA_HU	P22607	71.46	458.0	746.0	DB15685	Selpercatinib	approved; investigational	DB15685	Selpercatinib	approved; investigational	1.0
798	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00115	Cyanocobalamin	approved; nutraceutical	0.74
799	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00200	Hydroxocobalamin	approved	0.8
800	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00254	Doxycycline	approved; investigational; vet_approved	0.91
801	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00256	Lymecycline	approved; investigational	0.89
802	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00290	Bleomycin	approved; investigational	0.73
803	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00309	Vindesine	approved; investigational	0.78
804	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00361	Vinorelbine	approved; investigational	0.79
805	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00512	Vancomycin	approved	0.71
806	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00541	Vincristine	approved; investigational	0.78
807	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00560	Tigecycline	approved	0.96
808	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00570	Vinblastine	approved	0.78
809	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00595	Oxytetracycline	approved; investigational; vet_approved	0.89
810	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00615	Rifabutin	approved; investigational	0.74
811	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00618	Demeclocycline	approved	0.9
812	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00696	Ergotamine	approved	0.71
813	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00759	Tetracycline	approved; vet_approved	0.9
814	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00762	Irinotecan	approved; investigational	0.71
815	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00931	Metacycline	approved; investigational	0.89
816	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB00970	Dactinomycin	approved; investigational	0.73
817	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB01017	Minocycline	approved; investigational	1.0
818	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB01200	Bromocriptine	approved; investigational	0.72
819	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB01220	Rifaximin	approved; investigational	0.72
820	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB01301	Rolitetracycline	approved	0.89
821	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB01452	Diamorphine	approved; illicit; investigational	0.71
822	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB03614	Mecobalamin	approved; investigational	0.8
823	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB04865	Omacetaxine mepesuccinate	approved; investigational	0.7
824	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB04911	Oritavancin	approved; investigational	0.73
825	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB05109	Trabectedin	approved; investigational	0.75
826	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB06402	Telavancin	approved	0.73
827	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.89
828	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB11191	Cobamamide	approved	0.8
829	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB11641	Vinflunine	approved; investigational	0.79
830	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB11691	Naldemedine	approved; investigational	0.77
831	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB12035	Sarecycline	approved; investigational	0.91
832	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB12329	Eravacycline	approved; investigational	0.92
833	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB12455	Omadacycline	approved; investigational	0.96
834	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB12674	Lurbinectedin	approved; investigational	0.77
835	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB13345	Dihydroergocristine	approved; experimental	0.7
836	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB13997	Baloxavir marboxil	approved; investigational	0.71
837	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB01017	Minocycline	approved; investigational	DB15465	Benzhydrocodone	approved	0.7
838	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00115	Cyanocobalamin	approved; nutraceutical	0.74
839	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00200	Hydroxocobalamin	approved	0.8
840	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00254	Doxycycline	approved; investigational; vet_approved	0.91
841	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00256	Lymecycline	approved; investigational	0.89
842	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00290	Bleomycin	approved; investigational	0.73
843	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00309	Vindesine	approved; investigational	0.78
844	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00361	Vinorelbine	approved; investigational	0.79
845	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00512	Vancomycin	approved	0.71
846	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00541	Vincristine	approved; investigational	0.78
847	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00560	Tigecycline	approved	0.96
848	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00570	Vinblastine	approved	0.78
849	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00595	Oxytetracycline	approved; investigational; vet_approved	0.89
850	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00615	Rifabutin	approved; investigational	0.74
851	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00618	Demeclocycline	approved	0.9
852	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00696	Ergotamine	approved	0.71
853	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00759	Tetracycline	approved; vet_approved	0.9
854	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00762	Irinotecan	approved; investigational	0.71
855	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00931	Metacycline	approved; investigational	0.89
856	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB00970	Dactinomycin	approved; investigational	0.73
857	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB01017	Minocycline	approved; investigational	1.0
858	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB01200	Bromocriptine	approved; investigational	0.72
859	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB01220	Rifaximin	approved; investigational	0.72
860	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB01301	Rolitetracycline	approved	0.89
861	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB01452	Diamorphine	approved; illicit; investigational	0.71
862	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB03614	Mecobalamin	approved; investigational	0.8
863	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB04865	Omacetaxine mepesuccinate	approved; investigational	0.7
864	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB04911	Oritavancin	approved; investigational	0.73
865	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB05109	Trabectedin	approved; investigational	0.75
866	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB06402	Telavancin	approved	0.73
867	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.89
868	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB11191	Cobamamide	approved	0.8
869	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB11641	Vinflunine	approved; investigational	0.79
870	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB11691	Naldemedine	approved; investigational	0.77
871	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB12035	Sarecycline	approved; investigational	0.91
872	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB12329	Eravacycline	approved; investigational	0.92
873	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB12455	Omadacycline	approved; investigational	0.96
874	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB12674	Lurbinectedin	approved; investigational	0.77
875	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB13345	Dihydroergocristine	approved; experimental	0.7
876	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB13997	Baloxavir marboxil	approved; investigational	0.71
877	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB05157	KC706	investigational	DB15465	Benzhydrocodone	approved	0.7
878	sp|O14965|AURKA_HU	O15264	75.68	12.0	317.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
879	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB00319	Piperacillin	approved	0.87
880	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB00415	Ampicillin	approved; vet_approved	1.0
881	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB00417	Phenoxymethylpenicillin	approved; vet_approved	0.84
882	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB00578	Carbenicillin	approved; investigational	0.88
883	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB00607	Nafcillin	approved; investigational	0.76
884	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB00713	Oxacillin	approved; investigational	0.7
885	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB00739	Hetacillin	approved; vet_approved; withdrawn	0.83
886	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB00948	Mezlocillin	approved; investigational	0.78
887	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB01000	Cyclacillin	approved	0.84
888	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB01053	Benzylpenicillin	approved; vet_approved	0.95
889	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB01060	Amoxicillin	approved; vet_approved	0.98
890	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB01061	Azlocillin	approved	0.88
891	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB01602	Bacampicillin	approved; investigational	0.89
892	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB01603	Meticillin	approved; investigational	0.78
893	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB01604	Pivampicillin	approved	0.93
894	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB01605	Pivmecillinam	approved	0.73
895	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB01607	Ticarcillin	approved; investigational; vet_approved	0.83
896	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB09319	Carindacillin	approved; investigational	0.79
897	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB09320	Procaine benzylpenicillin	approved; vet_approved	0.88
898	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB12127	Sultamicillin	approved; investigational	0.81
899	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB12343	Temocillin	approved; investigational	0.73
900	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB00415	Ampicillin	approved; vet_approved	DB13337	Pheneticillin	approved	0.83
901	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB05294	Vandetanib	approved	DB00317	Gefitinib	approved; investigational	0.77
902	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB05294	Vandetanib	approved	DB00530	Erlotinib	approved; investigational	0.74
903	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB05294	Vandetanib	approved	DB05294	Vandetanib	approved	1.0
904	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB08221	N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
905	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB08896	Regorafenib	approved	DB00398	Sorafenib	approved; investigational	0.87
906	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB08896	Regorafenib	approved	DB08896	Regorafenib	approved	1.0
907	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB08901	Ponatinib	approved; investigational	DB08901	Ponatinib	approved; investigational	1.0
908	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
909	sp|O14965|AURKA_HU	Q02763	74.19	791.0	1090.0	DB14840	Ripretinib	approved	DB14840	Ripretinib	approved	1.0
910	sp|O14965|AURKA_HU	P35626	85.11	117.0	460.0	DB00171	ATP	investigational; nutraceutical	DB00118	Ademetionine	approved; investigational; nutraceutical	0.79
911	sp|O14965|AURKA_HU	P35626	85.11	117.0	460.0	DB00171	ATP	investigational; nutraceutical	DB00131	Adenosine phosphate	approved; investigational; nutraceutical	0.93
912	sp|O14965|AURKA_HU	P35626	85.11	117.0	460.0	DB00171	ATP	investigational; nutraceutical	DB00157	NADH	approved; nutraceutical	0.82
913	sp|O14965|AURKA_HU	P35626	85.11	117.0	460.0	DB00171	ATP	investigational; nutraceutical	DB00194	Vidarabine	approved; investigational	0.87
914	sp|O14965|AURKA_HU	P35626	85.11	117.0	460.0	DB00171	ATP	investigational; nutraceutical	DB00242	Cladribine	approved; investigational	0.76
915	sp|O14965|AURKA_HU	P35626	85.11	117.0	460.0	DB00171	ATP	investigational; nutraceutical	DB00631	Clofarabine	approved; investigational	0.72
916	sp|O14965|AURKA_HU	P35626	85.11	117.0	460.0	DB00171	ATP	investigational; nutraceutical	DB00640	Adenosine	approved; investigational	0.87
917	sp|O14965|AURKA_HU	P35626	85.11	117.0	460.0	DB00171	ATP	investigational; nutraceutical	DB01073	Fludarabine	approved	0.83
918	sp|O14965|AURKA_HU	P35626	85.11	117.0	460.0	DB00171	ATP	investigational; nutraceutical	DB01280	Nelarabine	approved; investigational	0.73
919	sp|O14965|AURKA_HU	P35626	85.11	117.0	460.0	DB00171	ATP	investigational; nutraceutical	DB03147	Flavin adenine dinucleotide	approved	0.73
920	sp|O14965|AURKA_HU	P35626	85.11	117.0	460.0	DB00171	ATP	investigational; nutraceutical	DB05528	Mipomersen	approved; investigational	0.7
921	sp|O14965|AURKA_HU	P35626	85.11	117.0	460.0	DB00171	ATP	investigational; nutraceutical	DB06213	Regadenoson	approved; investigational	0.74
922	sp|O14965|AURKA_HU	P35626	85.11	117.0	460.0	DB00171	ATP	investigational; nutraceutical	DB06441	Cangrelor	approved	0.77
923	sp|O14965|AURKA_HU	P35626	85.11	117.0	460.0	DB00171	ATP	investigational; nutraceutical	DB13156	Inosine pranobex	approved	0.7
924	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00115	Cyanocobalamin	approved; nutraceutical	0.74
925	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00200	Hydroxocobalamin	approved	0.8
926	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00254	Doxycycline	approved; investigational; vet_approved	0.91
927	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00256	Lymecycline	approved; investigational	0.89
928	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00290	Bleomycin	approved; investigational	0.73
929	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00309	Vindesine	approved; investigational	0.78
930	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00361	Vinorelbine	approved; investigational	0.79
931	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00512	Vancomycin	approved	0.71
932	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00541	Vincristine	approved; investigational	0.78
933	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00560	Tigecycline	approved	0.96
934	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00570	Vinblastine	approved	0.78
935	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00595	Oxytetracycline	approved; investigational; vet_approved	0.89
936	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00615	Rifabutin	approved; investigational	0.74
937	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00618	Demeclocycline	approved	0.9
938	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00696	Ergotamine	approved	0.71
939	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00759	Tetracycline	approved; vet_approved	0.9
940	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00762	Irinotecan	approved; investigational	0.71
941	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00931	Metacycline	approved; investigational	0.89
942	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB00970	Dactinomycin	approved; investigational	0.73
943	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB01017	Minocycline	approved; investigational	1.0
944	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB01200	Bromocriptine	approved; investigational	0.72
945	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB01220	Rifaximin	approved; investigational	0.72
946	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB01301	Rolitetracycline	approved	0.89
947	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB01452	Diamorphine	approved; illicit; investigational	0.71
948	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB03614	Mecobalamin	approved; investigational	0.8
949	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB04865	Omacetaxine mepesuccinate	approved; investigational	0.7
950	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB04911	Oritavancin	approved; investigational	0.73
951	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB05109	Trabectedin	approved; investigational	0.75
952	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB06402	Telavancin	approved	0.73
953	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.89
954	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB11191	Cobamamide	approved	0.8
955	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB11641	Vinflunine	approved; investigational	0.79
956	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB11691	Naldemedine	approved; investigational	0.77
957	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB12035	Sarecycline	approved; investigational	0.91
958	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB12329	Eravacycline	approved; investigational	0.92
959	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB12455	Omadacycline	approved; investigational	0.96
960	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB12674	Lurbinectedin	approved; investigational	0.77
961	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB13345	Dihydroergocristine	approved; experimental	0.7
962	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB13997	Baloxavir marboxil	approved; investigational	0.71
963	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB01017	Minocycline	approved; investigational	DB15465	Benzhydrocodone	approved	0.7
964	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
965	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB00945	Acetylsalicylic acid	approved; vet_approved	DB00945	Acetylsalicylic acid	approved; vet_approved	1.0
966	sp|O14965|AURKA_HU	Q8TD08	73.2	11.0	306.0	DB00945	Acetylsalicylic acid	approved; vet_approved	DB08814	Triflusal	approved; investigational	0.74
967	sp|O14965|AURKA_HU	P19525	90.32	183.0	547.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
968	sp|O14965|AURKA_HU	Q9HBH9	79.16	52.0	371.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
969	sp|O14965|AURKA_HU	P07949	75.43	699.0	1003.0	DB00398	Sorafenib	approved; investigational	DB00398	Sorafenib	approved; investigational	1.0
970	sp|O14965|AURKA_HU	P07949	75.43	699.0	1003.0	DB00398	Sorafenib	approved; investigational	DB08896	Regorafenib	approved	0.87
971	sp|O14965|AURKA_HU	P07949	75.43	699.0	1003.0	DB01809	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	experimental	DB09053	Ibrutinib	approved	0.74
972	sp|O14965|AURKA_HU	P07949	75.43	699.0	1003.0	DB05294	Vandetanib	approved	DB00317	Gefitinib	approved; investigational	0.77
973	sp|O14965|AURKA_HU	P07949	75.43	699.0	1003.0	DB05294	Vandetanib	approved	DB00530	Erlotinib	approved; investigational	0.74
974	sp|O14965|AURKA_HU	P07949	75.43	699.0	1003.0	DB05294	Vandetanib	approved	DB05294	Vandetanib	approved	1.0
975	sp|O14965|AURKA_HU	P07949	75.43	699.0	1003.0	DB08875	Cabozantinib	approved; investigational	DB08875	Cabozantinib	approved; investigational	1.0
976	sp|O14965|AURKA_HU	P07949	75.43	699.0	1003.0	DB08896	Regorafenib	approved	DB00398	Sorafenib	approved; investigational	0.87
977	sp|O14965|AURKA_HU	P07949	75.43	699.0	1003.0	DB08896	Regorafenib	approved	DB08896	Regorafenib	approved	1.0
978	sp|O14965|AURKA_HU	P07949	75.43	699.0	1003.0	DB08901	Ponatinib	approved; investigational	DB08901	Ponatinib	approved; investigational	1.0
979	sp|O14965|AURKA_HU	P07949	75.43	699.0	1003.0	DB09078	Lenvatinib	approved; investigational	DB09078	Lenvatinib	approved; investigational	1.0
980	sp|O14965|AURKA_HU	P07949	75.43	699.0	1003.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
981	sp|O14965|AURKA_HU	P07949	75.43	699.0	1003.0	DB12742	Amuvatinib	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
982	sp|O14965|AURKA_HU	P07949	75.43	699.0	1003.0	DB15685	Selpercatinib	approved; investigational	DB15685	Selpercatinib	approved; investigational	1.0
983	sp|O14965|AURKA_HU	Q86UE8	85.86	406.0	752.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
984	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB00115	Cyanocobalamin	approved; nutraceutical	0.74
985	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB00200	Hydroxocobalamin	approved	0.77
986	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB00290	Bleomycin	approved; investigational	0.72
987	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB00309	Vindesine	approved; investigational	0.76
988	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB00361	Vinorelbine	approved; investigational	0.77
989	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB00541	Vincristine	approved; investigational	0.76
990	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB00570	Vinblastine	approved	0.76
991	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB00615	Rifabutin	approved; investigational	0.71
992	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB00762	Irinotecan	approved; investigational	0.71
993	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB00970	Dactinomycin	approved; investigational	0.71
994	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB01200	Bromocriptine	approved; investigational	0.71
995	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB03147	Flavin adenine dinucleotide	approved	0.71
996	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB03614	Mecobalamin	approved; investigational	0.77
997	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB04911	Oritavancin	approved; investigational	0.71
998	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB05109	Trabectedin	approved; investigational	0.72
999	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB06402	Telavancin	approved	0.71
1000	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB06595	Midostaurin	approved; investigational	0.82
1001	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.7
1002	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB11191	Cobamamide	approved	0.78
1003	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB11641	Vinflunine	approved; investigational	0.77
1004	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB11691	Naldemedine	approved; investigational	0.72
1005	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB02152	K-252a	experimental	DB12674	Lurbinectedin	approved; investigational	0.75
1006	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB03115	5-Bromo-N-[(2S)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1007	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB05239	Cobimetinib	approved; investigational	DB05239	Cobimetinib	approved; investigational	1.0
1008	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB06616	Bosutinib	approved	DB06616	Bosutinib	approved	1.0
1009	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB06892	(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1010	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB07046	2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1011	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB07101	PD-0325901	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1012	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08130	N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1013	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08208	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1014	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB00115	Cyanocobalamin	approved; nutraceutical	0.72
1015	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB00200	Hydroxocobalamin	approved	0.8
1016	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB00256	Lymecycline	approved; investigational	0.7
1017	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB00290	Bleomycin	approved; investigational	0.72
1018	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB00309	Vindesine	approved; investigational	0.77
1019	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB00361	Vinorelbine	approved; investigational	0.78
1020	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB00541	Vincristine	approved; investigational	0.78
1021	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB00570	Vinblastine	approved	0.77
1022	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB00615	Rifabutin	approved; investigational	0.73
1023	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB00696	Ergotamine	approved	0.7
1024	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB00762	Irinotecan	approved; investigational	0.7
1025	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB00970	Dactinomycin	approved; investigational	0.71
1026	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB01200	Bromocriptine	approved; investigational	0.72
1027	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB01301	Rolitetracycline	approved	0.7
1028	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB03614	Mecobalamin	approved; investigational	0.8
1029	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB04911	Oritavancin	approved; investigational	0.73
1030	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB05109	Trabectedin	approved; investigational	0.74
1031	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB06402	Telavancin	approved	0.73
1032	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB08911	Trametinib	approved	1.0
1033	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.7
1034	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB11191	Cobamamide	approved	0.8
1035	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB11641	Vinflunine	approved; investigational	0.78
1036	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB11691	Naldemedine	approved; investigational	0.74
1037	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB12674	Lurbinectedin	approved; investigational	0.77
1038	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB08911	Trametinib	approved	DB13997	Baloxavir marboxil	approved; investigational	0.7
1039	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB11689	Selumetinib	approved; investigational	DB11689	Selumetinib	approved; investigational	1.0
1040	sp|O14965|AURKA_HU	Q02750	86.35	20.0	368.0	DB11689	Selumetinib	approved; investigational	DB11967	Binimetinib	approved; investigational	0.93
1041	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00115	Cyanocobalamin	approved; nutraceutical	0.74
1042	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00200	Hydroxocobalamin	approved	0.8
1043	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00254	Doxycycline	approved; investigational; vet_approved	0.91
1044	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00256	Lymecycline	approved; investigational	0.89
1045	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00290	Bleomycin	approved; investigational	0.73
1046	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00309	Vindesine	approved; investigational	0.78
1047	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00361	Vinorelbine	approved; investigational	0.79
1048	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00512	Vancomycin	approved	0.71
1049	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00541	Vincristine	approved; investigational	0.78
1050	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00560	Tigecycline	approved	0.96
1051	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00570	Vinblastine	approved	0.78
1052	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00595	Oxytetracycline	approved; investigational; vet_approved	0.89
1053	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00615	Rifabutin	approved; investigational	0.74
1054	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00618	Demeclocycline	approved	0.9
1055	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00696	Ergotamine	approved	0.71
1056	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00759	Tetracycline	approved; vet_approved	0.9
1057	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00762	Irinotecan	approved; investigational	0.71
1058	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00931	Metacycline	approved; investigational	0.89
1059	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB00970	Dactinomycin	approved; investigational	0.73
1060	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB01017	Minocycline	approved; investigational	1.0
1061	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB01200	Bromocriptine	approved; investigational	0.72
1062	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB01220	Rifaximin	approved; investigational	0.72
1063	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB01301	Rolitetracycline	approved	0.89
1064	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB01452	Diamorphine	approved; illicit; investigational	0.71
1065	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB03614	Mecobalamin	approved; investigational	0.8
1066	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB04865	Omacetaxine mepesuccinate	approved; investigational	0.7
1067	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB04911	Oritavancin	approved; investigational	0.73
1068	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB05109	Trabectedin	approved; investigational	0.75
1069	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB06402	Telavancin	approved	0.73
1070	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.89
1071	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB11191	Cobamamide	approved	0.8
1072	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB11641	Vinflunine	approved; investigational	0.79
1073	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB11691	Naldemedine	approved; investigational	0.77
1074	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB12035	Sarecycline	approved; investigational	0.91
1075	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB12329	Eravacycline	approved; investigational	0.92
1076	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB12455	Omadacycline	approved; investigational	0.96
1077	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB12674	Lurbinectedin	approved; investigational	0.77
1078	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB13345	Dihydroergocristine	approved; experimental	0.7
1079	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB13997	Baloxavir marboxil	approved; investigational	0.71
1080	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB01017	Minocycline	approved; investigational	DB15465	Benzhydrocodone	approved	0.7
1081	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1082	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB00945	Acetylsalicylic acid	approved; vet_approved	DB00945	Acetylsalicylic acid	approved; vet_approved	1.0
1083	sp|O14965|AURKA_HU	Q13164	73.95	52.0	350.0	DB00945	Acetylsalicylic acid	approved; vet_approved	DB08814	Triflusal	approved; investigational	0.74
1084	sp|O14965|AURKA_HU	P15056	74.94	415.0	717.0	DB00398	Sorafenib	approved; investigational	DB00398	Sorafenib	approved; investigational	1.0
1085	sp|O14965|AURKA_HU	P15056	74.94	415.0	717.0	DB00398	Sorafenib	approved; investigational	DB08896	Regorafenib	approved	0.87
1086	sp|O14965|AURKA_HU	P15056	74.94	415.0	717.0	DB05190	XL281	investigational	DB00398	Sorafenib	approved; investigational	1.0
1087	sp|O14965|AURKA_HU	P15056	74.94	415.0	717.0	DB05190	XL281	investigational	DB08896	Regorafenib	approved	0.87
1088	sp|O14965|AURKA_HU	P15056	74.94	415.0	717.0	DB05984	RAF-265	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1089	sp|O14965|AURKA_HU	P15056	74.94	415.0	717.0	DB06999	PLX-4720	experimental	DB08881	Vemurafenib	approved	0.83
1090	sp|O14965|AURKA_HU	P15056	74.94	415.0	717.0	DB07000	N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide	experimental	DB08881	Vemurafenib	approved	0.96
1091	sp|O14965|AURKA_HU	P15056	74.94	415.0	717.0	DB08553	(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1092	sp|O14965|AURKA_HU	P15056	74.94	415.0	717.0	DB08881	Vemurafenib	approved	DB08881	Vemurafenib	approved	1.0
1093	sp|O14965|AURKA_HU	P15056	74.94	415.0	717.0	DB08896	Regorafenib	approved	DB00398	Sorafenib	approved; investigational	0.87
1094	sp|O14965|AURKA_HU	P15056	74.94	415.0	717.0	DB08896	Regorafenib	approved	DB08896	Regorafenib	approved	1.0
1095	sp|O14965|AURKA_HU	P15056	74.94	415.0	717.0	DB08912	Dabrafenib	approved; investigational	DB08912	Dabrafenib	approved; investigational	1.0
1096	sp|O14965|AURKA_HU	P15056	74.94	415.0	717.0	DB11718	Encorafenib	approved; investigational	DB11718	Encorafenib	approved; investigational	1.0
1097	sp|O14965|AURKA_HU	P15056	74.94	415.0	717.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1098	sp|O14965|AURKA_HU	P15056	74.94	415.0	717.0	DB14840	Ripretinib	approved	DB14840	Ripretinib	approved	1.0
1099	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01254	Dasatinib	approved; investigational	DB01254	Dasatinib	approved; investigational	1.0
1100	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01761	4-[5-[2-(1-phenyl-ethylamino)-pyrimidin-4-yl]-1-methyl-4-(3-trifluoromethylphenyl)-1H-imidazol-2-yl]-piperidine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1101	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01807	N-[(3Z)-5-Tert-butyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-ylidene]-N'-(4-chlorophenyl)urea	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1102	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01948	1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1103	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01953	Inhibitor of P38 Kinase	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1104	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01988	6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1105	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB02195	3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1106	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB02277	1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1107	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB02352	3-(Benzyloxy)Pyridin-2-Amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1108	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB02873	1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1109	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB02984	4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline	experimental	DB00317	Gefitinib	approved; investigational	0.72
1110	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB02984	4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline	experimental	DB00530	Erlotinib	approved; investigational	0.79
1111	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB02984	4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline	experimental	DB05294	Vandetanib	approved	0.7
1112	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB03044	Doramapimod	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1113	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB03110	2-Chlorophenol	experimental	DB13154	Parachlorophenol	approved	0.81
1114	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB03980	4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1115	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB04338	SB220025	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1116	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB04632	4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1117	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB04797	Triazolopyridine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1118	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB05157	KC706	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1119	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB05412	Talmapimod	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1120	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB05470	VX-702	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1121	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB06518	R-1487	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1122	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB06882	1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1123	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB06940	N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1124	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB06991	N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1125	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB07138	Neflamapimod	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1126	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB07307	N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1127	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB07459	4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1128	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB07607	4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1129	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB07811	N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1130	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB07829	4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1131	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB07832	4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1132	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB07833	N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1133	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB07834	N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1134	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB07835	N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1135	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB07941	PH-797804	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1136	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB07942	2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1137	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB07943	SD-0006	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1138	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08064	N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1139	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08068	N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1140	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08091	3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1141	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08092	3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1142	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08093	3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1143	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08095	3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1144	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08096	8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1145	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08097	2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1146	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08242	N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1147	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08349	N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1148	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08351	N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1149	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08352	6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1150	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08395	2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1151	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08423	[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1152	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08424	[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1153	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08521	4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1154	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08522	4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1155	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB08730	3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1156	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1157	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00115	Cyanocobalamin	approved; nutraceutical	0.74
1158	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00200	Hydroxocobalamin	approved	0.8
1159	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00254	Doxycycline	approved; investigational; vet_approved	0.91
1160	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00256	Lymecycline	approved; investigational	0.89
1161	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00290	Bleomycin	approved; investigational	0.73
1162	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00309	Vindesine	approved; investigational	0.78
1163	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00361	Vinorelbine	approved; investigational	0.79
1164	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00512	Vancomycin	approved	0.71
1165	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00541	Vincristine	approved; investigational	0.78
1166	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00560	Tigecycline	approved	0.96
1167	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00570	Vinblastine	approved	0.78
1168	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00595	Oxytetracycline	approved; investigational; vet_approved	0.89
1169	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00615	Rifabutin	approved; investigational	0.74
1170	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00618	Demeclocycline	approved	0.9
1171	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00696	Ergotamine	approved	0.71
1172	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00759	Tetracycline	approved; vet_approved	0.9
1173	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00762	Irinotecan	approved; investigational	0.71
1174	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00931	Metacycline	approved; investigational	0.89
1175	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB00970	Dactinomycin	approved; investigational	0.73
1176	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB01017	Minocycline	approved; investigational	1.0
1177	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB01200	Bromocriptine	approved; investigational	0.72
1178	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB01220	Rifaximin	approved; investigational	0.72
1179	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB01301	Rolitetracycline	approved	0.89
1180	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB01452	Diamorphine	approved; illicit; investigational	0.71
1181	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB03614	Mecobalamin	approved; investigational	0.8
1182	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB04865	Omacetaxine mepesuccinate	approved; investigational	0.7
1183	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB04911	Oritavancin	approved; investigational	0.73
1184	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB05109	Trabectedin	approved; investigational	0.75
1185	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB06402	Telavancin	approved	0.73
1186	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.89
1187	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB11191	Cobamamide	approved	0.8
1188	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB11641	Vinflunine	approved; investigational	0.79
1189	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB11691	Naldemedine	approved; investigational	0.77
1190	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB12035	Sarecycline	approved; investigational	0.91
1191	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB12329	Eravacycline	approved; investigational	0.92
1192	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB12455	Omadacycline	approved; investigational	0.96
1193	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB12674	Lurbinectedin	approved; investigational	0.77
1194	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB13345	Dihydroergocristine	approved; experimental	0.7
1195	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB13997	Baloxavir marboxil	approved; investigational	0.71
1196	sp|O14965|AURKA_HU	Q16539	74.69	11.0	312.0	DB01017	Minocycline	approved; investigational	DB15465	Benzhydrocodone	approved	0.7
1197	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01064	Isoprenaline	approved; investigational	DB00221	Isoetharine	approved	0.8
1198	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01064	Isoprenaline	approved; investigational	DB00368	Norepinephrine	approved	0.89
1199	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01064	Isoprenaline	approved; investigational	DB00388	Phenylephrine	approved	0.81
1200	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01064	Isoprenaline	approved; investigational	DB00610	Metaraminol	approved; investigational	0.72
1201	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01064	Isoprenaline	approved; investigational	DB00668	Epinephrine	approved; vet_approved	0.94
1202	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01064	Isoprenaline	approved; investigational	DB00816	Orciprenaline	approved	0.87
1203	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01064	Isoprenaline	approved; investigational	DB00867	Ritodrine	approved; investigational	0.74
1204	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01064	Isoprenaline	approved; investigational	DB00871	Terbutaline	approved	0.86
1205	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01064	Isoprenaline	approved; investigational	DB01001	Salbutamol	approved; vet_approved	0.71
1206	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01064	Isoprenaline	approved; investigational	DB01064	Isoprenaline	approved; investigational	1.0
1207	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01064	Isoprenaline	approved; investigational	DB01102	Arbutamine	approved	0.86
1208	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01064	Isoprenaline	approved; investigational	DB01288	Fenoterol	approved; investigational	0.85
1209	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01064	Isoprenaline	approved; investigational	DB06707	Levonordefrin	approved	0.83
1210	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01064	Isoprenaline	approved; investigational	DB06814	Protokylol	approved; vet_approved	0.75
1211	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01064	Isoprenaline	approved; investigational	DB11610	Oxilofrine	approved	0.7
1212	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01064	Isoprenaline	approved; investigational	DB13139	Levosalbutamol	approved; investigational	0.71
1213	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01169	Arsenic trioxide	approved; investigational	DB01169	Arsenic trioxide	approved; investigational	1.0
1214	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB02116	Olomoucine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1215	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB02482	Phosphonothreonine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1216	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB02733	Purvalanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1217	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB04338	SB220025	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1218	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB06195	Seliciclib	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1219	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB06641	Perifosine	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1220	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB06877	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1221	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB07010	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1222	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB07264	(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1223	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB07788	(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1224	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB07794	5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1225	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB07905	(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1226	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB08513	[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1227	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB08521	4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1228	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB11120	Turpentine	approved; experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1229	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB13930	Ulixertinib	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1230	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00115	Cyanocobalamin	approved; nutraceutical	0.74
1231	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00200	Hydroxocobalamin	approved	0.8
1232	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00254	Doxycycline	approved; investigational; vet_approved	0.91
1233	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00256	Lymecycline	approved; investigational	0.89
1234	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00290	Bleomycin	approved; investigational	0.73
1235	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00309	Vindesine	approved; investigational	0.78
1236	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00361	Vinorelbine	approved; investigational	0.79
1237	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00512	Vancomycin	approved	0.71
1238	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00541	Vincristine	approved; investigational	0.78
1239	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00560	Tigecycline	approved	0.96
1240	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00570	Vinblastine	approved	0.78
1241	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00595	Oxytetracycline	approved; investigational; vet_approved	0.89
1242	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00615	Rifabutin	approved; investigational	0.74
1243	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00618	Demeclocycline	approved	0.9
1244	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00696	Ergotamine	approved	0.71
1245	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00759	Tetracycline	approved; vet_approved	0.9
1246	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00762	Irinotecan	approved; investigational	0.71
1247	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00931	Metacycline	approved; investigational	0.89
1248	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB00970	Dactinomycin	approved; investigational	0.73
1249	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB01017	Minocycline	approved; investigational	1.0
1250	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB01200	Bromocriptine	approved; investigational	0.72
1251	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB01220	Rifaximin	approved; investigational	0.72
1252	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB01301	Rolitetracycline	approved	0.89
1253	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB01452	Diamorphine	approved; illicit; investigational	0.71
1254	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB03614	Mecobalamin	approved; investigational	0.8
1255	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB04865	Omacetaxine mepesuccinate	approved; investigational	0.7
1256	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB04911	Oritavancin	approved; investigational	0.73
1257	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB05109	Trabectedin	approved; investigational	0.75
1258	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB06402	Telavancin	approved	0.73
1259	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.89
1260	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB11191	Cobamamide	approved	0.8
1261	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB11641	Vinflunine	approved; investigational	0.79
1262	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB11691	Naldemedine	approved; investigational	0.77
1263	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB12035	Sarecycline	approved; investigational	0.91
1264	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB12329	Eravacycline	approved; investigational	0.92
1265	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB12455	Omadacycline	approved; investigational	0.96
1266	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB12674	Lurbinectedin	approved; investigational	0.77
1267	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB13345	Dihydroergocristine	approved; experimental	0.7
1268	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB13997	Baloxavir marboxil	approved; investigational	0.71
1269	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB01017	Minocycline	approved; investigational	DB15465	Benzhydrocodone	approved	0.7
1270	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB00945	Acetylsalicylic acid	approved; vet_approved	DB00945	Acetylsalicylic acid	approved; vet_approved	1.0
1271	sp|O14965|AURKA_HU	P28482	72.21	24.0	315.0	DB00945	Acetylsalicylic acid	approved; vet_approved	DB08814	Triflusal	approved; investigational	0.74
1272	sp|O14965|AURKA_HU	Q00534	74.94	10.0	312.0	DB03496	Alvocidib	experimental; investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1273	sp|O14965|AURKA_HU	Q00534	74.94	10.0	312.0	DB07379	(2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1274	sp|O14965|AURKA_HU	Q00534	74.94	10.0	312.0	DB07795	Fisetin	experimental	DB07776	Flavone	approved; experimental	0.7
1275	sp|O14965|AURKA_HU	Q00534	74.94	10.0	312.0	DB09073	Palbociclib	approved; investigational	DB09073	Palbociclib	approved; investigational	1.0
1276	sp|O14965|AURKA_HU	Q00534	74.94	10.0	312.0	DB11730	Ribociclib	approved; investigational	DB11730	Ribociclib	approved; investigational	1.0
1277	sp|O14965|AURKA_HU	Q00534	74.94	10.0	312.0	DB12001	Abemaciclib	approved; investigational	DB12001	Abemaciclib	approved; investigational	1.0
1278	sp|O14965|AURKA_HU	Q00537	71.22	188.0	475.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1279	sp|O14965|AURKA_HU	Q00536	71.46	161.0	449.0	DB07766	(2Z,3E)-2,3'-biindole-2',3(1H,1'H)-dione 3-{O-[(3R)-3,4-dihydroxybutyl]oxime}	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1280	sp|O14965|AURKA_HU	Q00536	71.46	161.0	449.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1281	sp|O14965|AURKA_HU	P04049	82.13	283.0	614.0	DB00398	Sorafenib	approved; investigational	DB00398	Sorafenib	approved; investigational	1.0
1282	sp|O14965|AURKA_HU	P04049	82.13	283.0	614.0	DB00398	Sorafenib	approved; investigational	DB08896	Regorafenib	approved	0.87
1283	sp|O14965|AURKA_HU	P04049	82.13	283.0	614.0	DB05190	XL281	investigational	DB00398	Sorafenib	approved; investigational	1.0
1284	sp|O14965|AURKA_HU	P04049	82.13	283.0	614.0	DB05190	XL281	investigational	DB08896	Regorafenib	approved	0.87
1285	sp|O14965|AURKA_HU	P04049	82.13	283.0	614.0	DB05268	iCo-007	investigational	DB00398	Sorafenib	approved; investigational	1.0
1286	sp|O14965|AURKA_HU	P04049	82.13	283.0	614.0	DB05268	iCo-007	investigational	DB08896	Regorafenib	approved	0.87
1287	sp|O14965|AURKA_HU	P04049	82.13	283.0	614.0	DB08862	Cholecystokinin	approved; investigational	DB00398	Sorafenib	approved; investigational	1.0
1288	sp|O14965|AURKA_HU	P04049	82.13	283.0	614.0	DB08862	Cholecystokinin	approved; investigational	DB08896	Regorafenib	approved	0.87
1289	sp|O14965|AURKA_HU	P04049	82.13	283.0	614.0	DB08896	Regorafenib	approved	DB00398	Sorafenib	approved; investigational	0.87
1290	sp|O14965|AURKA_HU	P04049	82.13	283.0	614.0	DB08896	Regorafenib	approved	DB08896	Regorafenib	approved	1.0
1291	sp|O14965|AURKA_HU	P04049	82.13	283.0	614.0	DB08912	Dabrafenib	approved; investigational	DB08912	Dabrafenib	approved; investigational	1.0
1292	sp|O14965|AURKA_HU	P04049	82.13	283.0	614.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1293	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB00605	Sulindac	approved; investigational	DB00605	Sulindac	approved; investigational	1.0
1294	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01169	Arsenic trioxide	approved; investigational	DB01169	Arsenic trioxide	approved; investigational	1.0
1295	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB02733	Purvalanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1296	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB04604	5-iodotubercidin	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1297	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB06195	Seliciclib	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1298	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB08862	Cholecystokinin	approved; investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1299	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB13930	Ulixertinib	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1300	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00115	Cyanocobalamin	approved; nutraceutical	0.74
1301	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00200	Hydroxocobalamin	approved	0.8
1302	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00254	Doxycycline	approved; investigational; vet_approved	0.91
1303	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00256	Lymecycline	approved; investigational	0.89
1304	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00290	Bleomycin	approved; investigational	0.73
1305	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00309	Vindesine	approved; investigational	0.78
1306	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00361	Vinorelbine	approved; investigational	0.79
1307	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00512	Vancomycin	approved	0.71
1308	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00541	Vincristine	approved; investigational	0.78
1309	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00560	Tigecycline	approved	0.96
1310	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00570	Vinblastine	approved	0.78
1311	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00595	Oxytetracycline	approved; investigational; vet_approved	0.89
1312	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00615	Rifabutin	approved; investigational	0.74
1313	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00618	Demeclocycline	approved	0.9
1314	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00696	Ergotamine	approved	0.71
1315	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00759	Tetracycline	approved; vet_approved	0.9
1316	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00762	Irinotecan	approved; investigational	0.71
1317	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00931	Metacycline	approved; investigational	0.89
1318	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB00970	Dactinomycin	approved; investigational	0.73
1319	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB01017	Minocycline	approved; investigational	1.0
1320	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB01200	Bromocriptine	approved; investigational	0.72
1321	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB01220	Rifaximin	approved; investigational	0.72
1322	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB01301	Rolitetracycline	approved	0.89
1323	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB01452	Diamorphine	approved; illicit; investigational	0.71
1324	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB03614	Mecobalamin	approved; investigational	0.8
1325	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB04865	Omacetaxine mepesuccinate	approved; investigational	0.7
1326	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB04911	Oritavancin	approved; investigational	0.73
1327	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB05109	Trabectedin	approved; investigational	0.75
1328	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB06402	Telavancin	approved	0.73
1329	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.89
1330	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB11191	Cobamamide	approved	0.8
1331	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB11641	Vinflunine	approved; investigational	0.79
1332	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB11691	Naldemedine	approved; investigational	0.77
1333	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB12035	Sarecycline	approved; investigational	0.91
1334	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB12329	Eravacycline	approved; investigational	0.92
1335	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB12455	Omadacycline	approved; investigational	0.96
1336	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB12674	Lurbinectedin	approved; investigational	0.77
1337	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB13345	Dihydroergocristine	approved; experimental	0.7
1338	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB13997	Baloxavir marboxil	approved; investigational	0.71
1339	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB01017	Minocycline	approved; investigational	DB15465	Benzhydrocodone	approved	0.7
1340	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB00945	Acetylsalicylic acid	approved; vet_approved	DB00945	Acetylsalicylic acid	approved; vet_approved	1.0
1341	sp|O14965|AURKA_HU	P27361	72.21	41.0	332.0	DB00945	Acetylsalicylic acid	approved; vet_approved	DB08814	Triflusal	approved; investigational	0.74
1342	sp|O14965|AURKA_HU	Q9UKI8	94.29	363.0	743.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1343	sp|O14965|AURKA_HU	Q9NWZ3	86.1	105.0	452.0	DB08590	1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1344	sp|O14965|AURKA_HU	Q9NWZ3	86.1	105.0	452.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1345	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00115	Cyanocobalamin	approved; nutraceutical	0.74
1346	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00200	Hydroxocobalamin	approved	0.8
1347	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00254	Doxycycline	approved; investigational; vet_approved	0.91
1348	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00256	Lymecycline	approved; investigational	0.89
1349	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00290	Bleomycin	approved; investigational	0.73
1350	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00309	Vindesine	approved; investigational	0.78
1351	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00361	Vinorelbine	approved; investigational	0.79
1352	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00512	Vancomycin	approved	0.71
1353	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00541	Vincristine	approved; investigational	0.78
1354	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00560	Tigecycline	approved	0.96
1355	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00570	Vinblastine	approved	0.78
1356	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00595	Oxytetracycline	approved; investigational; vet_approved	0.89
1357	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00615	Rifabutin	approved; investigational	0.74
1358	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00618	Demeclocycline	approved	0.9
1359	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00696	Ergotamine	approved	0.71
1360	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00759	Tetracycline	approved; vet_approved	0.9
1361	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00762	Irinotecan	approved; investigational	0.71
1362	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00931	Metacycline	approved; investigational	0.89
1363	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB00970	Dactinomycin	approved; investigational	0.73
1364	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB01017	Minocycline	approved; investigational	1.0
1365	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB01200	Bromocriptine	approved; investigational	0.72
1366	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB01220	Rifaximin	approved; investigational	0.72
1367	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB01301	Rolitetracycline	approved	0.89
1368	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB01452	Diamorphine	approved; illicit; investigational	0.71
1369	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB03614	Mecobalamin	approved; investigational	0.8
1370	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB04865	Omacetaxine mepesuccinate	approved; investigational	0.7
1371	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB04911	Oritavancin	approved; investigational	0.73
1372	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB05109	Trabectedin	approved; investigational	0.75
1373	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB06402	Telavancin	approved	0.73
1374	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.89
1375	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB11191	Cobamamide	approved	0.8
1376	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB11641	Vinflunine	approved; investigational	0.79
1377	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB11691	Naldemedine	approved; investigational	0.77
1378	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB12035	Sarecycline	approved; investigational	0.91
1379	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB12329	Eravacycline	approved; investigational	0.92
1380	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB12455	Omadacycline	approved; investigational	0.96
1381	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB12674	Lurbinectedin	approved; investigational	0.77
1382	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB13345	Dihydroergocristine	approved; experimental	0.7
1383	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB13997	Baloxavir marboxil	approved; investigational	0.71
1384	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB01017	Minocycline	approved; investigational	DB15465	Benzhydrocodone	approved	0.7
1385	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00115	Cyanocobalamin	approved; nutraceutical	0.74
1386	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00200	Hydroxocobalamin	approved	0.8
1387	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00254	Doxycycline	approved; investigational; vet_approved	0.91
1388	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00256	Lymecycline	approved; investigational	0.89
1389	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00290	Bleomycin	approved; investigational	0.73
1390	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00309	Vindesine	approved; investigational	0.78
1391	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00361	Vinorelbine	approved; investigational	0.79
1392	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00512	Vancomycin	approved	0.71
1393	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00541	Vincristine	approved; investigational	0.78
1394	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00560	Tigecycline	approved	0.96
1395	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00570	Vinblastine	approved	0.78
1396	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00595	Oxytetracycline	approved; investigational; vet_approved	0.89
1397	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00615	Rifabutin	approved; investigational	0.74
1398	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00618	Demeclocycline	approved	0.9
1399	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00696	Ergotamine	approved	0.71
1400	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00759	Tetracycline	approved; vet_approved	0.9
1401	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00762	Irinotecan	approved; investigational	0.71
1402	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00931	Metacycline	approved; investigational	0.89
1403	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB00970	Dactinomycin	approved; investigational	0.73
1404	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB01017	Minocycline	approved; investigational	1.0
1405	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB01200	Bromocriptine	approved; investigational	0.72
1406	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB01220	Rifaximin	approved; investigational	0.72
1407	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB01301	Rolitetracycline	approved	0.89
1408	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB01452	Diamorphine	approved; illicit; investigational	0.71
1409	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB03614	Mecobalamin	approved; investigational	0.8
1410	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB04865	Omacetaxine mepesuccinate	approved; investigational	0.7
1411	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB04911	Oritavancin	approved; investigational	0.73
1412	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB05109	Trabectedin	approved; investigational	0.75
1413	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB06402	Telavancin	approved	0.73
1414	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.89
1415	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB11191	Cobamamide	approved	0.8
1416	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB11641	Vinflunine	approved; investigational	0.79
1417	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB11691	Naldemedine	approved; investigational	0.77
1418	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB12035	Sarecycline	approved; investigational	0.91
1419	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB12329	Eravacycline	approved; investigational	0.92
1420	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB12455	Omadacycline	approved; investigational	0.96
1421	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB12674	Lurbinectedin	approved; investigational	0.77
1422	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB13345	Dihydroergocristine	approved; experimental	0.7
1423	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB13997	Baloxavir marboxil	approved; investigational	0.71
1424	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB05157	KC706	investigational	DB15465	Benzhydrocodone	approved	0.7
1425	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB08896	Regorafenib	approved	DB00398	Sorafenib	approved; investigational	0.87
1426	sp|O14965|AURKA_HU	Q15759	74.44	13.0	313.0	DB08896	Regorafenib	approved	DB08896	Regorafenib	approved	1.0
1427	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB06616	Bosutinib	approved	DB06616	Bosutinib	approved	1.0
1428	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB00115	Cyanocobalamin	approved; nutraceutical	0.72
1429	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB00200	Hydroxocobalamin	approved	0.8
1430	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB00256	Lymecycline	approved; investigational	0.7
1431	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB00290	Bleomycin	approved; investigational	0.72
1432	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB00309	Vindesine	approved; investigational	0.77
1433	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB00361	Vinorelbine	approved; investigational	0.78
1434	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB00541	Vincristine	approved; investigational	0.78
1435	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB00570	Vinblastine	approved	0.77
1436	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB00615	Rifabutin	approved; investigational	0.73
1437	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB00696	Ergotamine	approved	0.7
1438	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB00762	Irinotecan	approved; investigational	0.7
1439	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB00970	Dactinomycin	approved; investigational	0.71
1440	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB01200	Bromocriptine	approved; investigational	0.72
1441	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB01301	Rolitetracycline	approved	0.7
1442	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB03614	Mecobalamin	approved; investigational	0.8
1443	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB04911	Oritavancin	approved; investigational	0.73
1444	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB05109	Trabectedin	approved; investigational	0.74
1445	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB06402	Telavancin	approved	0.73
1446	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB08911	Trametinib	approved	1.0
1447	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.7
1448	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB11191	Cobamamide	approved	0.8
1449	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB11641	Vinflunine	approved; investigational	0.78
1450	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB11691	Naldemedine	approved; investigational	0.74
1451	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB12674	Lurbinectedin	approved; investigational	0.77
1452	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB08911	Trametinib	approved	DB13997	Baloxavir marboxil	approved; investigational	0.7
1453	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB11689	Selumetinib	approved; investigational	DB11689	Selumetinib	approved; investigational	1.0
1454	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB11689	Selumetinib	approved; investigational	DB11967	Binimetinib	approved; investigational	0.93
1455	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB11967	Binimetinib	approved; investigational	DB11689	Selumetinib	approved; investigational	0.93
1456	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB11967	Binimetinib	approved; investigational	DB11967	Binimetinib	approved; investigational	1.0
1457	sp|O14965|AURKA_HU	P36507	83.62	38.0	375.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1458	sp|O14965|AURKA_HU	O15146	70.47	569.0	853.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1459	sp|O14965|AURKA_HU	Q13163	71.96	131.0	421.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1460	sp|O14965|AURKA_HU	P50750	74.69	17.0	318.0	DB03496	Alvocidib	experimental; investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1461	sp|O14965|AURKA_HU	P50750	74.69	17.0	318.0	DB06195	Seliciclib	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1462	sp|O14965|AURKA_HU	P08922	70.97	1934.0	2220.0	DB11986	Entrectinib	approved; investigational	DB11986	Entrectinib	approved; investigational	1.0
1463	sp|O14965|AURKA_HU	P08922	70.97	1934.0	2220.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1464	sp|O14965|AURKA_HU	Q96Q40	85.61	56.0	401.0	DB00171	ATP	investigational; nutraceutical	DB00118	Ademetionine	approved; investigational; nutraceutical	0.79
1465	sp|O14965|AURKA_HU	Q96Q40	85.61	56.0	401.0	DB00171	ATP	investigational; nutraceutical	DB00131	Adenosine phosphate	approved; investigational; nutraceutical	0.93
1466	sp|O14965|AURKA_HU	Q96Q40	85.61	56.0	401.0	DB00171	ATP	investigational; nutraceutical	DB00157	NADH	approved; nutraceutical	0.82
1467	sp|O14965|AURKA_HU	Q96Q40	85.61	56.0	401.0	DB00171	ATP	investigational; nutraceutical	DB00194	Vidarabine	approved; investigational	0.87
1468	sp|O14965|AURKA_HU	Q96Q40	85.61	56.0	401.0	DB00171	ATP	investigational; nutraceutical	DB00242	Cladribine	approved; investigational	0.76
1469	sp|O14965|AURKA_HU	Q96Q40	85.61	56.0	401.0	DB00171	ATP	investigational; nutraceutical	DB00631	Clofarabine	approved; investigational	0.72
1470	sp|O14965|AURKA_HU	Q96Q40	85.61	56.0	401.0	DB00171	ATP	investigational; nutraceutical	DB00640	Adenosine	approved; investigational	0.87
1471	sp|O14965|AURKA_HU	Q96Q40	85.61	56.0	401.0	DB00171	ATP	investigational; nutraceutical	DB01073	Fludarabine	approved	0.83
1472	sp|O14965|AURKA_HU	Q96Q40	85.61	56.0	401.0	DB00171	ATP	investigational; nutraceutical	DB01280	Nelarabine	approved; investigational	0.73
1473	sp|O14965|AURKA_HU	Q96Q40	85.61	56.0	401.0	DB00171	ATP	investigational; nutraceutical	DB03147	Flavin adenine dinucleotide	approved	0.73
1474	sp|O14965|AURKA_HU	Q96Q40	85.61	56.0	401.0	DB00171	ATP	investigational; nutraceutical	DB05528	Mipomersen	approved; investigational	0.7
1475	sp|O14965|AURKA_HU	Q96Q40	85.61	56.0	401.0	DB00171	ATP	investigational; nutraceutical	DB06213	Regadenoson	approved; investigational	0.74
1476	sp|O14965|AURKA_HU	Q96Q40	85.61	56.0	401.0	DB00171	ATP	investigational; nutraceutical	DB06441	Cangrelor	approved	0.77
1477	sp|O14965|AURKA_HU	Q96Q40	85.61	56.0	401.0	DB00171	ATP	investigational; nutraceutical	DB13156	Inosine pranobex	approved	0.7
1478	sp|O14965|AURKA_HU	Q96Q40	85.61	56.0	401.0	DB06486	Enzastaurin	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1479	sp|O14965|AURKA_HU	Q96Q40	85.61	56.0	401.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1480	sp|O14965|AURKA_HU	P50613	71.96	8.0	298.0	DB02482	Phosphonothreonine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1481	sp|O14965|AURKA_HU	P50613	71.96	8.0	298.0	DB03496	Alvocidib	experimental; investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1482	sp|O14965|AURKA_HU	P50613	71.96	8.0	298.0	DB05969	SNS-032	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1483	sp|O14965|AURKA_HU	P50613	71.96	8.0	298.0	DB06195	Seliciclib	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1484	sp|O14965|AURKA_HU	P10398	78.16	257.0	572.0	DB00171	ATP	investigational; nutraceutical	DB00118	Ademetionine	approved; investigational; nutraceutical	0.79
1485	sp|O14965|AURKA_HU	P10398	78.16	257.0	572.0	DB00171	ATP	investigational; nutraceutical	DB00131	Adenosine phosphate	approved; investigational; nutraceutical	0.93
1486	sp|O14965|AURKA_HU	P10398	78.16	257.0	572.0	DB00171	ATP	investigational; nutraceutical	DB00157	NADH	approved; nutraceutical	0.82
1487	sp|O14965|AURKA_HU	P10398	78.16	257.0	572.0	DB00171	ATP	investigational; nutraceutical	DB00194	Vidarabine	approved; investigational	0.87
1488	sp|O14965|AURKA_HU	P10398	78.16	257.0	572.0	DB00171	ATP	investigational; nutraceutical	DB00242	Cladribine	approved; investigational	0.76
1489	sp|O14965|AURKA_HU	P10398	78.16	257.0	572.0	DB00171	ATP	investigational; nutraceutical	DB00631	Clofarabine	approved; investigational	0.72
1490	sp|O14965|AURKA_HU	P10398	78.16	257.0	572.0	DB00171	ATP	investigational; nutraceutical	DB00640	Adenosine	approved; investigational	0.87
1491	sp|O14965|AURKA_HU	P10398	78.16	257.0	572.0	DB00171	ATP	investigational; nutraceutical	DB01073	Fludarabine	approved	0.83
1492	sp|O14965|AURKA_HU	P10398	78.16	257.0	572.0	DB00171	ATP	investigational; nutraceutical	DB01280	Nelarabine	approved; investigational	0.73
1493	sp|O14965|AURKA_HU	P10398	78.16	257.0	572.0	DB00171	ATP	investigational; nutraceutical	DB03147	Flavin adenine dinucleotide	approved	0.73
1494	sp|O14965|AURKA_HU	P10398	78.16	257.0	572.0	DB00171	ATP	investigational; nutraceutical	DB05528	Mipomersen	approved; investigational	0.7
1495	sp|O14965|AURKA_HU	P10398	78.16	257.0	572.0	DB00171	ATP	investigational; nutraceutical	DB06213	Regadenoson	approved; investigational	0.74
1496	sp|O14965|AURKA_HU	P10398	78.16	257.0	572.0	DB00171	ATP	investigational; nutraceutical	DB06441	Cangrelor	approved	0.77
1497	sp|O14965|AURKA_HU	P10398	78.16	257.0	572.0	DB00171	ATP	investigational; nutraceutical	DB13156	Inosine pranobex	approved	0.7
1498	sp|O14965|AURKA_HU	P46734	79.16	15.0	334.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1499	sp|O14965|AURKA_HU	Q8IW41	74.19	11.0	310.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1500	sp|O14965|AURKA_HU	Q16832	71.96	555.0	845.0	DB08896	Regorafenib	approved	DB00398	Sorafenib	approved; investigational	0.87
1501	sp|O14965|AURKA_HU	Q16832	71.96	555.0	845.0	DB08896	Regorafenib	approved	DB08896	Regorafenib	approved	1.0
1502	sp|O14965|AURKA_HU	Q16832	71.96	555.0	845.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1503	sp|O14965|AURKA_HU	P52564	74.44	22.0	322.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1504	sp|O14965|AURKA_HU	P49759	94.54	97.0	478.0	DB04367	Debromohymenialdisine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1505	sp|O14965|AURKA_HU	P49759	94.54	97.0	478.0	DB06376	CHGN111	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1506	sp|O14965|AURKA_HU	P49759	94.54	97.0	478.0	DB08691	ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1507	sp|O14965|AURKA_HU	P49759	94.54	97.0	478.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1508	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB00171	ATP	investigational; nutraceutical	DB00118	Ademetionine	approved; investigational; nutraceutical	0.79
1509	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB00171	ATP	investigational; nutraceutical	DB00131	Adenosine phosphate	approved; investigational; nutraceutical	0.93
1510	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB00171	ATP	investigational; nutraceutical	DB00157	NADH	approved; nutraceutical	0.82
1511	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB00171	ATP	investigational; nutraceutical	DB00194	Vidarabine	approved; investigational	0.87
1512	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB00171	ATP	investigational; nutraceutical	DB00242	Cladribine	approved; investigational	0.76
1513	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB00171	ATP	investigational; nutraceutical	DB00631	Clofarabine	approved; investigational	0.72
1514	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB00171	ATP	investigational; nutraceutical	DB00640	Adenosine	approved; investigational	0.87
1515	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB00171	ATP	investigational; nutraceutical	DB01073	Fludarabine	approved	0.83
1516	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB00171	ATP	investigational; nutraceutical	DB01280	Nelarabine	approved; investigational	0.73
1517	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB00171	ATP	investigational; nutraceutical	DB03147	Flavin adenine dinucleotide	approved	0.73
1518	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB00171	ATP	investigational; nutraceutical	DB05528	Mipomersen	approved; investigational	0.7
1519	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB00171	ATP	investigational; nutraceutical	DB06213	Regadenoson	approved; investigational	0.74
1520	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB00171	ATP	investigational; nutraceutical	DB06441	Cangrelor	approved	0.77
1521	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB00171	ATP	investigational; nutraceutical	DB13156	Inosine pranobex	approved	0.7
1522	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB08865	Crizotinib	approved	DB08865	Crizotinib	approved	1.0
1523	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB09063	Ceritinib	approved	DB09063	Ceritinib	approved	1.0
1524	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB11363	Alectinib	approved; investigational	DB11363	Alectinib	approved; investigational	1.0
1525	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1526	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB12130	Lorlatinib	approved; investigational	DB12130	Lorlatinib	approved; investigational	1.0
1527	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB12141	Gilteritinib	approved; investigational	DB12141	Gilteritinib	approved; investigational	1.0
1528	sp|O14965|AURKA_HU	Q9UM73	72.46	1090.0	1382.0	DB12267	Brigatinib	approved; investigational	DB12267	Brigatinib	approved; investigational	1.0
1529	sp|O14965|AURKA_HU	Q9HAZ1	96.28	90.0	478.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1530	sp|O14965|AURKA_HU	Q08345	73.7	605.0	902.0	DB00619	Imatinib	approved	DB00619	Imatinib	approved	1.0
1531	sp|O14965|AURKA_HU	Q08345	73.7	605.0	902.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1532	sp|O14965|AURKA_HU	P11802	74.19	2.0	301.0	DB02733	Purvalanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1533	sp|O14965|AURKA_HU	P11802	74.19	2.0	301.0	DB03496	Alvocidib	experimental; investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1534	sp|O14965|AURKA_HU	P11802	74.19	2.0	301.0	DB09073	Palbociclib	approved; investigational	DB09073	Palbociclib	approved; investigational	1.0
1535	sp|O14965|AURKA_HU	P11802	74.19	2.0	301.0	DB11730	Ribociclib	approved; investigational	DB11730	Ribociclib	approved; investigational	1.0
1536	sp|O14965|AURKA_HU	P11802	74.19	2.0	301.0	DB12001	Abemaciclib	approved; investigational	DB12001	Abemaciclib	approved; investigational	1.0
1537	sp|O14965|AURKA_HU	P11802	74.19	2.0	301.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1538	sp|O14965|AURKA_HU	P53671	78.66	280.0	597.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1539	sp|O14965|AURKA_HU	P49760	95.53	103.0	488.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1540	sp|O14965|AURKA_HU	P33981	71.22	513.0	800.0	DB01782	Pyrazolanthrone	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1541	sp|O14965|AURKA_HU	P33981	71.22	513.0	800.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1542	sp|O14965|AURKA_HU	P33981	71.22	513.0	800.0	DB15498	BOS172722	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1543	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00115	Cyanocobalamin	approved; nutraceutical	0.74
1544	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00200	Hydroxocobalamin	approved	0.8
1545	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00254	Doxycycline	approved; investigational; vet_approved	0.91
1546	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00256	Lymecycline	approved; investigational	0.89
1547	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00290	Bleomycin	approved; investigational	0.73
1548	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00309	Vindesine	approved; investigational	0.78
1549	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00361	Vinorelbine	approved; investigational	0.79
1550	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00512	Vancomycin	approved	0.71
1551	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00541	Vincristine	approved; investigational	0.78
1552	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00560	Tigecycline	approved	0.96
1553	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00570	Vinblastine	approved	0.78
1554	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00595	Oxytetracycline	approved; investigational; vet_approved	0.89
1555	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00615	Rifabutin	approved; investigational	0.74
1556	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00618	Demeclocycline	approved	0.9
1557	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00696	Ergotamine	approved	0.71
1558	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00759	Tetracycline	approved; vet_approved	0.9
1559	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00762	Irinotecan	approved; investigational	0.71
1560	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00931	Metacycline	approved; investigational	0.89
1561	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB00970	Dactinomycin	approved; investigational	0.73
1562	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB01017	Minocycline	approved; investigational	1.0
1563	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB01200	Bromocriptine	approved; investigational	0.72
1564	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB01220	Rifaximin	approved; investigational	0.72
1565	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB01301	Rolitetracycline	approved	0.89
1566	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB01452	Diamorphine	approved; illicit; investigational	0.71
1567	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB03614	Mecobalamin	approved; investigational	0.8
1568	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB04865	Omacetaxine mepesuccinate	approved; investigational	0.7
1569	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB04911	Oritavancin	approved; investigational	0.73
1570	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB05109	Trabectedin	approved; investigational	0.75
1571	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB06402	Telavancin	approved	0.73
1572	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.89
1573	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB11191	Cobamamide	approved	0.8
1574	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB11641	Vinflunine	approved; investigational	0.79
1575	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB11691	Naldemedine	approved; investigational	0.77
1576	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB12035	Sarecycline	approved; investigational	0.91
1577	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB12329	Eravacycline	approved; investigational	0.92
1578	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB12455	Omadacycline	approved; investigational	0.96
1579	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB12674	Lurbinectedin	approved; investigational	0.77
1580	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB13345	Dihydroergocristine	approved; experimental	0.7
1581	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB13997	Baloxavir marboxil	approved; investigational	0.71
1582	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB01017	Minocycline	approved; investigational	DB15465	Benzhydrocodone	approved	0.7
1583	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB00945	Acetylsalicylic acid	approved; vet_approved	DB00945	Acetylsalicylic acid	approved; vet_approved	1.0
1584	sp|O14965|AURKA_HU	Q16659	74.19	18.0	317.0	DB00945	Acetylsalicylic acid	approved; vet_approved	DB08814	Triflusal	approved; investigational	0.74
1585	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00115	Cyanocobalamin	approved; nutraceutical	0.74
1586	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00200	Hydroxocobalamin	approved	0.8
1587	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00254	Doxycycline	approved; investigational; vet_approved	0.91
1588	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00256	Lymecycline	approved; investigational	0.89
1589	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00290	Bleomycin	approved; investigational	0.73
1590	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00309	Vindesine	approved; investigational	0.78
1591	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00361	Vinorelbine	approved; investigational	0.79
1592	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00512	Vancomycin	approved	0.71
1593	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00541	Vincristine	approved; investigational	0.78
1594	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00560	Tigecycline	approved	0.96
1595	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00570	Vinblastine	approved	0.78
1596	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00595	Oxytetracycline	approved; investigational; vet_approved	0.89
1597	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00615	Rifabutin	approved; investigational	0.74
1598	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00618	Demeclocycline	approved	0.9
1599	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00696	Ergotamine	approved	0.71
1600	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00759	Tetracycline	approved; vet_approved	0.9
1601	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00762	Irinotecan	approved; investigational	0.71
1602	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00931	Metacycline	approved; investigational	0.89
1603	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB00970	Dactinomycin	approved; investigational	0.73
1604	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB01017	Minocycline	approved; investigational	1.0
1605	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB01200	Bromocriptine	approved; investigational	0.72
1606	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB01220	Rifaximin	approved; investigational	0.72
1607	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB01301	Rolitetracycline	approved	0.89
1608	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB01452	Diamorphine	approved; illicit; investigational	0.71
1609	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB03614	Mecobalamin	approved; investigational	0.8
1610	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB04865	Omacetaxine mepesuccinate	approved; investigational	0.7
1611	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB04911	Oritavancin	approved; investigational	0.73
1612	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB05109	Trabectedin	approved; investigational	0.75
1613	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB06402	Telavancin	approved	0.73
1614	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB09093	Chlortetracycline	approved; investigational; vet_approved	0.89
1615	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB11191	Cobamamide	approved	0.8
1616	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB11641	Vinflunine	approved; investigational	0.79
1617	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB11691	Naldemedine	approved; investigational	0.77
1618	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB12035	Sarecycline	approved; investigational	0.91
1619	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB12329	Eravacycline	approved; investigational	0.92
1620	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB12455	Omadacycline	approved; investigational	0.96
1621	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB12674	Lurbinectedin	approved; investigational	0.77
1622	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB13345	Dihydroergocristine	approved; experimental	0.7
1623	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB13997	Baloxavir marboxil	approved; investigational	0.71
1624	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB01017	Minocycline	approved; investigational	DB15465	Benzhydrocodone	approved	0.7
1625	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1626	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB00945	Acetylsalicylic acid	approved; vet_approved	DB00945	Acetylsalicylic acid	approved; vet_approved	1.0
1627	sp|O14965|AURKA_HU	P31152	73.45	20.0	316.0	DB00945	Acetylsalicylic acid	approved; vet_approved	DB08814	Triflusal	approved; investigational	0.74
1628	sp|O14965|AURKA_HU	P49840	71.71	116.0	405.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1629	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB00171	ATP	investigational; nutraceutical	DB00118	Ademetionine	approved; investigational; nutraceutical	0.79
1630	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB00171	ATP	investigational; nutraceutical	DB00131	Adenosine phosphate	approved; investigational; nutraceutical	0.93
1631	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB00171	ATP	investigational; nutraceutical	DB00157	NADH	approved; nutraceutical	0.82
1632	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB00171	ATP	investigational; nutraceutical	DB00194	Vidarabine	approved; investigational	0.87
1633	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB00171	ATP	investigational; nutraceutical	DB00242	Cladribine	approved; investigational	0.76
1634	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB00171	ATP	investigational; nutraceutical	DB00631	Clofarabine	approved; investigational	0.72
1635	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB00171	ATP	investigational; nutraceutical	DB00640	Adenosine	approved; investigational	0.87
1636	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB00171	ATP	investigational; nutraceutical	DB01073	Fludarabine	approved	0.83
1637	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB00171	ATP	investigational; nutraceutical	DB01280	Nelarabine	approved; investigational	0.73
1638	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB00171	ATP	investigational; nutraceutical	DB03147	Flavin adenine dinucleotide	approved	0.73
1639	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB00171	ATP	investigational; nutraceutical	DB05528	Mipomersen	approved; investigational	0.7
1640	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB00171	ATP	investigational; nutraceutical	DB06213	Regadenoson	approved; investigational	0.74
1641	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB00171	ATP	investigational; nutraceutical	DB06441	Cangrelor	approved	0.77
1642	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB00171	ATP	investigational; nutraceutical	DB13156	Inosine pranobex	approved	0.7
1643	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB01765	(5-hydroxyindolo[1,2-a]quinazolin-7-yl)acetic acid	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1644	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB02170	1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1645	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB02709	Resveratrol	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1646	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB03035	1,8-Di-Hydroxy-4-Nitro-Anthraquinone	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1647	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB03127	Benzamidine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1648	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB03924	5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone	experimental	DB01204	Mitoxantrone	approved; investigational	0.81
1649	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB03924	5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone	experimental	DB04816	Dantron	approved; investigational; withdrawn	0.74
1650	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB04216	Quercetin	experimental; investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1651	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00118	Ademetionine	approved; investigational; nutraceutical	0.76
1652	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00131	Adenosine phosphate	approved; investigational; nutraceutical	0.88
1653	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00157	NADH	approved; nutraceutical	0.8
1654	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00194	Vidarabine	approved; investigational	0.82
1655	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00242	Cladribine	approved; investigational	0.72
1656	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00640	Adenosine	approved; investigational	0.82
1657	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB01073	Fludarabine	approved	0.79
1658	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB01280	Nelarabine	approved; investigational	0.71
1659	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB03147	Flavin adenine dinucleotide	approved	0.73
1660	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB05528	Mipomersen	approved; investigational	0.71
1661	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB06213	Regadenoson	approved; investigational	0.75
1662	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB06441	Cangrelor	approved	0.78
1663	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB04462	Tetrabromo-2-Benzotriazole	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1664	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB04719	DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1665	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB04720	S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1666	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB04721	N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1667	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB07715	Emodin	investigational	DB04816	Dantron	approved; investigational; withdrawn	0.84
1668	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB07715	Emodin	investigational	DB11157	Anthralin	approved	0.78
1669	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB07715	Emodin	investigational	DB11994	Diacerein	approved; investigational	0.74
1670	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB07802	3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1671	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB08338	19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1672	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB08340	N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1673	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB08345	4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1674	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB08353	2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1675	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB08354	2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1676	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB08360	2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1677	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB08362	N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1678	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB08473	Dichlororibofuranosylbenzimidazole	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1679	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB08660	Quinalizarin	experimental	DB04816	Dantron	approved; investigational; withdrawn	0.87
1680	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB08660	Quinalizarin	experimental	DB11157	Anthralin	approved	0.81
1681	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB08846	Ellagic acid	investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1682	sp|O14965|AURKA_HU	P68400	74.94	27.0	329.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1683	sp|O14965|AURKA_HU	P49761	97.77	238.0	632.0	DB07664	K-00546	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1684	sp|O14965|AURKA_HU	P49761	97.77	238.0	632.0	DB08691	ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1685	sp|O14965|AURKA_HU	P49761	97.77	238.0	632.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1686	sp|O14965|AURKA_HU	P19784	74.94	32.0	334.0	DB07546	[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1687	sp|O14965|AURKA_HU	P19784	74.94	32.0	334.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1688	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB00761	Potassium chloride	approved; withdrawn	1.0
1689	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB01164	Calcium chloride	approved	1.0
1690	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB01345	Potassium cation	approved; investigational	1.0
1691	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB01370	Aluminium	approved; investigational	1.0
1692	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB01377	Magnesium oxide	approved	1.0
1693	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB01378	Magnesium cation	approved; nutraceutical	1.0
1694	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB01574	Attapulgite	approved; vet_approved	1.0
1695	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB01592	Iron	approved	1.0
1696	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB01593	Zinc	approved; investigational	1.0
1697	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB06215	Ferumoxytol	approved; investigational	1.0
1698	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB06715	Potassium Iodide	approved	1.0
1699	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB06723	Aluminum hydroxide	approved; investigational	1.0
1700	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB06757	Manganese	approved; nutraceutical	1.0
1701	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB06767	Ammonium chloride	approved; investigational; vet_approved	1.0
1702	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB08913	Radium Ra 223 dichloride	approved; investigational	1.0
1703	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09104	Magnesium hydroxide	approved; investigational	1.0
1704	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09129	Chromic chloride	approved	1.0
1705	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09130	Copper	approved; investigational	1.0
1706	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09145	Water	approved	1.0
1707	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09153	Sodium chloride	approved; vet_approved	1.0
1708	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09155	Helium	approved; investigational; vet_approved	1.0
1709	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09278	Activated charcoal	approved	1.0
1710	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09293	Iodide I-131	approved; investigational	1.0
1711	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09314	Technetium Tc-99m pertechnetate	approved; investigational	1.0
1712	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09315	Xenon-133	approved	1.0
1713	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09316	Thallous Chloride	approved	1.0
1714	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09325	Sodium fluoride	approved	1.0
1715	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09326	Ammonia N-13	approved	1.0
1716	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09398	Fluoride ion F-18	approved	1.0
1717	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09407	Magnesium chloride	approved	1.0
1718	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09420	Iodide I-123	approved	1.0
1719	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09443	Krypton Kr 81m	approved	1.0
1720	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09461	Xenon Xe-127	approved	1.0
1721	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09479	Rubidium Rb-82	approved; investigational	1.0
1722	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB09498	Strontium chloride Sr-89	approved; investigational	1.0
1723	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB11056	Stannous chloride	approved	1.0
1724	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB11072	Hydrogen fluoride	approved; investigational	1.0
1725	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB11119	Sodium iodide	approved	1.0
1726	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB11134	Cupric oxide	approved	1.0
1727	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB11135	Selenium	approved; investigational; vet_approved	1.0
1728	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB11136	Chromium	approved	1.0
1729	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB11137	Molybdenum	approved	1.0
1730	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB11140	Chromium Cr-51	approved	1.0
1731	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB11151	Sodium hydroxide	approved	1.0
1732	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB11153	Potassium hydroxide	approved	1.0
1733	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB11159	Sodium sulfide	approved	1.0
1734	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB11257	Fluoride ion	approved	1.0
1735	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB11342	Aluminum oxide	approved	1.0
1736	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB11346	Rubidium	approved; investigational	1.0
1737	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB11573	Aluminum chlorohydrate	approved	1.0
1738	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB11589	Neon	approved; investigational	1.0
1739	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB12091	Gadolinium	approved; investigational	1.0
1740	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB12754	Iodide	approved; experimental	1.0
1741	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB12965	Silver	approved; investigational	1.0
1742	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB12982	Silicon	approved; investigational	1.0
1743	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB13076	Yttrium Y-90	approved; investigational	1.0
1744	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB13249	Magnesium silicate	approved	1.0
1745	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB13949	Ferric cation	approved	1.0
1746	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB13971	Vanadium	approved; experimental	1.0
1747	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB13982	Lutetium Lu-177	approved	1.0
1748	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB13987	Strontium chloride	approved	1.0
1749	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB14151	Phosphorus	approved; experimental	1.0
1750	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB14206	Cobalt chloride	approved; experimental	1.0
1751	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB14500	Potassium	approved; experimental	1.0
1752	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB14506	Lithium hydroxide	approved; withdrawn	1.0
1753	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB14513	Magnesium	approved; experimental; investigational	1.0
1754	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB14533	Zinc chloride	approved; investigational	1.0
1755	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB14550	Gallium chloride Ga-67	approved	1.0
1756	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01356	Lithium cation	experimental	DB14574	Cobalt	approved; experimental	1.0
1757	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01772	3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1758	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01793	SB-409513	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1759	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB01950	AR-AO-14418	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1760	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB02010	Staurosporine	experimental	DB00115	Cyanocobalamin	approved; nutraceutical	0.7
1761	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB02010	Staurosporine	experimental	DB00200	Hydroxocobalamin	approved	0.73
1762	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB02010	Staurosporine	experimental	DB00309	Vindesine	approved; investigational	0.71
1763	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB02010	Staurosporine	experimental	DB00361	Vinorelbine	approved; investigational	0.72
1764	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB02010	Staurosporine	experimental	DB00541	Vincristine	approved; investigational	0.71
1765	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB02010	Staurosporine	experimental	DB00570	Vinblastine	approved	0.71
1766	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB02010	Staurosporine	experimental	DB03614	Mecobalamin	approved; investigational	0.73
1767	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB02010	Staurosporine	experimental	DB06595	Midostaurin	approved; investigational	0.95
1768	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB02010	Staurosporine	experimental	DB11191	Cobamamide	approved	0.73
1769	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB02010	Staurosporine	experimental	DB11641	Vinflunine	approved; investigational	0.72
1770	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB02010	Staurosporine	experimental	DB12674	Lurbinectedin	approved; investigational	0.71
1771	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB02052	Indirubin-3'-monoxime	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1772	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB03444	6-bromoindirubin-3'-oxime	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1773	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB04014	Alsterpaullone	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1774	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00118	Ademetionine	approved; investigational; nutraceutical	0.76
1775	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00131	Adenosine phosphate	approved; investigational; nutraceutical	0.88
1776	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00157	NADH	approved; nutraceutical	0.8
1777	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00194	Vidarabine	approved; investigational	0.82
1778	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00242	Cladribine	approved; investigational	0.72
1779	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB00640	Adenosine	approved; investigational	0.82
1780	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB01073	Fludarabine	approved	0.79
1781	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB01280	Nelarabine	approved; investigational	0.71
1782	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB03147	Flavin adenine dinucleotide	approved	0.73
1783	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB05528	Mipomersen	approved; investigational	0.71
1784	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB06213	Regadenoson	approved; investigational	0.75
1785	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	experimental	DB06441	Cangrelor	approved	0.78
1786	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB07014	2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1787	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB07058	5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1788	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB07149	(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1789	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB07584	N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1790	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB07585	5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1791	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB07676	3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1792	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB07812	N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1793	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB07859	4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1794	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB07947	ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1795	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB08073	(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1796	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1797	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB12129	Tideglusib	investigational; withdrawn	SORRY!!	Cannot find	structurally similar	approved molecules
1798	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14507	Lithium citrate	approved	DB04272	Citric acid	approved; nutraceutical; vet_approved	1.0
1799	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14507	Lithium citrate	approved	DB06784	Gallium citrate Ga-67	approved	1.0
1800	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14507	Lithium citrate	approved	DB09125	Potassium citrate	approved; investigational; vet_approved	1.0
1801	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14507	Lithium citrate	approved	DB09154	Sodium citrate	approved; investigational	1.0
1802	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14507	Lithium citrate	approved	DB09275	Bismuth subcitrate potassium	approved; investigational	1.0
1803	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14507	Lithium citrate	approved	DB09501	Ferric ammonium citrate	approved; experimental	1.0
1804	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14507	Lithium citrate	approved	DB11093	Calcium citrate	approved; investigational	1.0
1805	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14507	Lithium citrate	approved	DB11110	Magnesium citrate	approved	1.0
1806	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14507	Lithium citrate	approved	DB13995	Ferric pyrophosphate citrate	approved; investigational	0.84
1807	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14507	Lithium citrate	approved	DB14507	Lithium citrate	approved	1.0
1808	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14507	Lithium citrate	approved	DB14520	Tetraferric tricitrate decahydrate	approved	1.0
1809	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14508	Lithium succinate	experimental	DB00139	Succinic acid	approved; nutraceutical	1.0
1810	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14508	Lithium succinate	experimental	DB01440	gamma-Hydroxybutyric acid	approved; illicit; investigational	0.91
1811	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14508	Lithium succinate	experimental	DB09072	Sodium oxybate	approved	0.91
1812	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14508	Lithium succinate	experimental	DB14489	Ferrous succinate	approved	1.0
1813	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14509	Lithium carbonate	approved	DB01390	Sodium bicarbonate	approved	1.0
1814	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14509	Lithium carbonate	approved	DB06724	Calcium carbonate	approved; investigational	1.0
1815	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14509	Lithium carbonate	approved	DB06792	Lanthanum carbonate	approved	1.0
1816	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14509	Lithium carbonate	approved	DB09460	Sodium carbonate	approved	1.0
1817	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14509	Lithium carbonate	approved	DB09481	Magnesium carbonate	approved; investigational	1.0
1818	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14509	Lithium carbonate	approved	DB11098	Potassium bicarbonate	approved	1.0
1819	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14509	Lithium carbonate	approved	DB13322	Hydrotalcite	approved; experimental; investigational	1.0
1820	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14509	Lithium carbonate	approved	DB13977	Potassium carbonate	approved	1.0
1821	sp|O14965|AURKA_HU	P49841	72.95	51.0	345.0	DB14509	Lithium carbonate	approved	DB14509	Lithium carbonate	approved	1.0
1822	sp|O14965|AURKA_HU	Q9H2X6	71.96	127.0	417.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1823	sp|O14965|AURKA_HU	Q8IIR9	73.7	35.0	332.0	DB11638	Artenimol	experimental; investigational	DB06697	Artemether	approved	0.99
1824	sp|O14965|AURKA_HU	Q8IIR9	73.7	35.0	332.0	DB11638	Artenimol	experimental; investigational	DB09274	Artesunate	approved; investigational	0.9
1825	sp|O14965|AURKA_HU	Q8IIR9	73.7	35.0	332.0	DB11638	Artenimol	experimental; investigational	DB13851	Artemotil	approved	0.99
1826	sp|O14965|AURKA_HU	O75460	88.34	487.0	843.0	DB07382	N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1827	sp|O14965|AURKA_HU	O75460	88.34	487.0	843.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1828	sp|O14965|AURKA_HU	Q13523	81.64	677.0	1006.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1829	sp|O14965|AURKA_HU	P49336	81.14	11.0	338.0	DB03496	Alvocidib	experimental; investigational	SORRY!!	Cannot find	structurally similar	approved molecules
1830	sp|O14965|AURKA_HU	Q8TDR2	80.65	198.0	523.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1831	sp|O14965|AURKA_HU	O00238	72.46	198.0	490.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1832	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB04608	9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1833	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB07006	9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1834	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB07226	N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1835	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB07257	4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1836	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB07265	3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1837	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB08365	8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide	experimental	DB00200	Hydroxocobalamin	approved	0.73
1838	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB08365	8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide	experimental	DB00309	Vindesine	approved; investigational	0.71
1839	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB08365	8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide	experimental	DB00361	Vinorelbine	approved; investigational	0.72
1840	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB08365	8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide	experimental	DB00541	Vincristine	approved; investigational	0.72
1841	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB08365	8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide	experimental	DB00570	Vinblastine	approved	0.72
1842	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB08365	8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide	experimental	DB03614	Mecobalamin	approved; investigational	0.73
1843	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB08365	8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide	experimental	DB11191	Cobamamide	approved	0.73
1844	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB08365	8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide	experimental	DB11641	Vinflunine	approved; investigational	0.73
1845	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB08365	8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide	experimental	DB12674	Lurbinectedin	approved; investigational	0.72
1846	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB11740	MK-1775	investigational	DB00200	Hydroxocobalamin	approved	0.71
1847	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB11740	MK-1775	investigational	DB03614	Mecobalamin	approved; investigational	0.71
1848	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB11740	MK-1775	investigational	DB11191	Cobamamide	approved	0.72
1849	sp|O14965|AURKA_HU	P30291	77.92	265.0	579.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1850	sp|O14965|AURKA_HU	Q04771	72.21	203.0	494.0	DB00171	ATP	investigational; nutraceutical	DB00118	Ademetionine	approved; investigational; nutraceutical	0.79
1851	sp|O14965|AURKA_HU	Q04771	72.21	203.0	494.0	DB00171	ATP	investigational; nutraceutical	DB00131	Adenosine phosphate	approved; investigational; nutraceutical	0.93
1852	sp|O14965|AURKA_HU	Q04771	72.21	203.0	494.0	DB00171	ATP	investigational; nutraceutical	DB00157	NADH	approved; nutraceutical	0.82
1853	sp|O14965|AURKA_HU	Q04771	72.21	203.0	494.0	DB00171	ATP	investigational; nutraceutical	DB00194	Vidarabine	approved; investigational	0.87
1854	sp|O14965|AURKA_HU	Q04771	72.21	203.0	494.0	DB00171	ATP	investigational; nutraceutical	DB00242	Cladribine	approved; investigational	0.76
1855	sp|O14965|AURKA_HU	Q04771	72.21	203.0	494.0	DB00171	ATP	investigational; nutraceutical	DB00631	Clofarabine	approved; investigational	0.72
1856	sp|O14965|AURKA_HU	Q04771	72.21	203.0	494.0	DB00171	ATP	investigational; nutraceutical	DB00640	Adenosine	approved; investigational	0.87
1857	sp|O14965|AURKA_HU	Q04771	72.21	203.0	494.0	DB00171	ATP	investigational; nutraceutical	DB01073	Fludarabine	approved	0.83
1858	sp|O14965|AURKA_HU	Q04771	72.21	203.0	494.0	DB00171	ATP	investigational; nutraceutical	DB01280	Nelarabine	approved; investigational	0.73
1859	sp|O14965|AURKA_HU	Q04771	72.21	203.0	494.0	DB00171	ATP	investigational; nutraceutical	DB03147	Flavin adenine dinucleotide	approved	0.73
1860	sp|O14965|AURKA_HU	Q04771	72.21	203.0	494.0	DB00171	ATP	investigational; nutraceutical	DB05528	Mipomersen	approved; investigational	0.7
1861	sp|O14965|AURKA_HU	Q04771	72.21	203.0	494.0	DB00171	ATP	investigational; nutraceutical	DB06213	Regadenoson	approved; investigational	0.74
1862	sp|O14965|AURKA_HU	Q04771	72.21	203.0	494.0	DB00171	ATP	investigational; nutraceutical	DB06441	Cangrelor	approved	0.77
1863	sp|O14965|AURKA_HU	Q04771	72.21	203.0	494.0	DB00171	ATP	investigational; nutraceutical	DB13156	Inosine pranobex	approved	0.7
1864	sp|O14965|AURKA_HU	Q04771	72.21	203.0	494.0	DB08597	Dorsomorphin	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1865	sp|O14965|AURKA_HU	Q04771	72.21	203.0	494.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1866	sp|O14965|AURKA_HU	P51617	75.93	210.0	516.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1867	sp|O14965|AURKA_HU	P37023	72.21	198.0	489.0	DB00171	ATP	investigational; nutraceutical	DB00118	Ademetionine	approved; investigational; nutraceutical	0.79
1868	sp|O14965|AURKA_HU	P37023	72.21	198.0	489.0	DB00171	ATP	investigational; nutraceutical	DB00131	Adenosine phosphate	approved; investigational; nutraceutical	0.93
1869	sp|O14965|AURKA_HU	P37023	72.21	198.0	489.0	DB00171	ATP	investigational; nutraceutical	DB00157	NADH	approved; nutraceutical	0.82
1870	sp|O14965|AURKA_HU	P37023	72.21	198.0	489.0	DB00171	ATP	investigational; nutraceutical	DB00194	Vidarabine	approved; investigational	0.87
1871	sp|O14965|AURKA_HU	P37023	72.21	198.0	489.0	DB00171	ATP	investigational; nutraceutical	DB00242	Cladribine	approved; investigational	0.76
1872	sp|O14965|AURKA_HU	P37023	72.21	198.0	489.0	DB00171	ATP	investigational; nutraceutical	DB00631	Clofarabine	approved; investigational	0.72
1873	sp|O14965|AURKA_HU	P37023	72.21	198.0	489.0	DB00171	ATP	investigational; nutraceutical	DB00640	Adenosine	approved; investigational	0.87
1874	sp|O14965|AURKA_HU	P37023	72.21	198.0	489.0	DB00171	ATP	investigational; nutraceutical	DB01073	Fludarabine	approved	0.83
1875	sp|O14965|AURKA_HU	P37023	72.21	198.0	489.0	DB00171	ATP	investigational; nutraceutical	DB01280	Nelarabine	approved; investigational	0.73
1876	sp|O14965|AURKA_HU	P37023	72.21	198.0	489.0	DB00171	ATP	investigational; nutraceutical	DB03147	Flavin adenine dinucleotide	approved	0.73
1877	sp|O14965|AURKA_HU	P37023	72.21	198.0	489.0	DB00171	ATP	investigational; nutraceutical	DB05528	Mipomersen	approved; investigational	0.7
1878	sp|O14965|AURKA_HU	P37023	72.21	198.0	489.0	DB00171	ATP	investigational; nutraceutical	DB06213	Regadenoson	approved; investigational	0.74
1879	sp|O14965|AURKA_HU	P37023	72.21	198.0	489.0	DB00171	ATP	investigational; nutraceutical	DB06441	Cangrelor	approved	0.77
1880	sp|O14965|AURKA_HU	P37023	72.21	198.0	489.0	DB00171	ATP	investigational; nutraceutical	DB13156	Inosine pranobex	approved	0.7
1881	sp|O14965|AURKA_HU	P36897	71.22	203.0	490.0	DB03921	4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1882	sp|O14965|AURKA_HU	P36897	71.22	203.0	490.0	DB04434	Naphthyridine Inhibitor	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1883	sp|O14965|AURKA_HU	P36897	71.22	203.0	490.0	DB04480	3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1884	sp|O14965|AURKA_HU	P36897	71.22	203.0	490.0	DB07152	N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1885	sp|O14965|AURKA_HU	P36897	71.22	203.0	490.0	DB07267	2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1886	sp|O14965|AURKA_HU	P36897	71.22	203.0	490.0	DB08450	N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1887	sp|O14965|AURKA_HU	P36897	71.22	203.0	490.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1888	sp|O14965|AURKA_HU	P37173	73.7	239.0	536.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1889	sp|O14965|AURKA_HU	Q13873	75.68	192.0	497.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1890	sp|O14965|AURKA_HU	P36896	71.71	203.0	492.0	DB00171	ATP	investigational; nutraceutical	DB00118	Ademetionine	approved; investigational; nutraceutical	0.79
1891	sp|O14965|AURKA_HU	P36896	71.71	203.0	492.0	DB00171	ATP	investigational; nutraceutical	DB00131	Adenosine phosphate	approved; investigational; nutraceutical	0.93
1892	sp|O14965|AURKA_HU	P36896	71.71	203.0	492.0	DB00171	ATP	investigational; nutraceutical	DB00157	NADH	approved; nutraceutical	0.82
1893	sp|O14965|AURKA_HU	P36896	71.71	203.0	492.0	DB00171	ATP	investigational; nutraceutical	DB00194	Vidarabine	approved; investigational	0.87
1894	sp|O14965|AURKA_HU	P36896	71.71	203.0	492.0	DB00171	ATP	investigational; nutraceutical	DB00242	Cladribine	approved; investigational	0.76
1895	sp|O14965|AURKA_HU	P36896	71.71	203.0	492.0	DB00171	ATP	investigational; nutraceutical	DB00631	Clofarabine	approved; investigational	0.72
1896	sp|O14965|AURKA_HU	P36896	71.71	203.0	492.0	DB00171	ATP	investigational; nutraceutical	DB00640	Adenosine	approved; investigational	0.87
1897	sp|O14965|AURKA_HU	P36896	71.71	203.0	492.0	DB00171	ATP	investigational; nutraceutical	DB01073	Fludarabine	approved	0.83
1898	sp|O14965|AURKA_HU	P36896	71.71	203.0	492.0	DB00171	ATP	investigational; nutraceutical	DB01280	Nelarabine	approved; investigational	0.73
1899	sp|O14965|AURKA_HU	P36896	71.71	203.0	492.0	DB00171	ATP	investigational; nutraceutical	DB03147	Flavin adenine dinucleotide	approved	0.73
1900	sp|O14965|AURKA_HU	P36896	71.71	203.0	492.0	DB00171	ATP	investigational; nutraceutical	DB05528	Mipomersen	approved; investigational	0.7
1901	sp|O14965|AURKA_HU	P36896	71.71	203.0	492.0	DB00171	ATP	investigational; nutraceutical	DB06213	Regadenoson	approved; investigational	0.74
1902	sp|O14965|AURKA_HU	P36896	71.71	203.0	492.0	DB00171	ATP	investigational; nutraceutical	DB06441	Cangrelor	approved	0.77
1903	sp|O14965|AURKA_HU	P36896	71.71	203.0	492.0	DB00171	ATP	investigational; nutraceutical	DB13156	Inosine pranobex	approved	0.7
1904	sp|O14965|AURKA_HU	P36896	71.71	203.0	492.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1905	sp|O14965|AURKA_HU	Q9HCP0	70.47	7.0	291.0	DB08325	2-({6-[(3-Chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)ethanol	experimental	SORRY!!	Cannot find	structurally similar	approved molecules
1906	sp|O14965|AURKA_HU	P0C264	71.96	5.0	295.0	DB12010	Fostamatinib	approved; investigational	DB12010	Fostamatinib	approved; investigational	1.0
1907	sp|O14965|AURKA_HU	Q16671	75.43	202.0	506.0	DB00171	ATP	investigational; nutraceutical	DB00118	Ademetionine	approved; investigational; nutraceutical	0.79
1908	sp|O14965|AURKA_HU	Q16671	75.43	202.0	506.0	DB00171	ATP	investigational; nutraceutical	DB00131	Adenosine phosphate	approved; investigational; nutraceutical	0.93
1909	sp|O14965|AURKA_HU	Q16671	75.43	202.0	506.0	DB00171	ATP	investigational; nutraceutical	DB00157	NADH	approved; nutraceutical	0.82
1910	sp|O14965|AURKA_HU	Q16671	75.43	202.0	506.0	DB00171	ATP	investigational; nutraceutical	DB00194	Vidarabine	approved; investigational	0.87
1911	sp|O14965|AURKA_HU	Q16671	75.43	202.0	506.0	DB00171	ATP	investigational; nutraceutical	DB00242	Cladribine	approved; investigational	0.76
1912	sp|O14965|AURKA_HU	Q16671	75.43	202.0	506.0	DB00171	ATP	investigational; nutraceutical	DB00631	Clofarabine	approved; investigational	0.72
1913	sp|O14965|AURKA_HU	Q16671	75.43	202.0	506.0	DB00171	ATP	investigational; nutraceutical	DB00640	Adenosine	approved; investigational	0.87
1914	sp|O14965|AURKA_HU	Q16671	75.43	202.0	506.0	DB00171	ATP	investigational; nutraceutical	DB01073	Fludarabine	approved	0.83
1915	sp|O14965|AURKA_HU	Q16671	75.43	202.0	506.0	DB00171	ATP	investigational; nutraceutical	DB01280	Nelarabine	approved; investigational	0.73
1916	sp|O14965|AURKA_HU	Q16671	75.43	202.0	506.0	DB00171	ATP	investigational; nutraceutical	DB03147	Flavin adenine dinucleotide	approved	0.73
1917	sp|O14965|AURKA_HU	Q16671	75.43	202.0	506.0	DB00171	ATP	investigational; nutraceutical	DB05528	Mipomersen	approved; investigational	0.7
1918	sp|O14965|AURKA_HU	Q16671	75.43	202.0	506.0	DB00171	ATP	investigational; nutraceutical	DB06213	Regadenoson	approved; investigational	0.74
1919	sp|O14965|AURKA_HU	Q16671	75.43	202.0	506.0	DB00171	ATP	investigational; nutraceutical	DB06441	Cangrelor	approved	0.77
1920	sp|O14965|AURKA_HU	Q16671	75.43	202.0	506.0	DB00171	ATP	investigational; nutraceutical	DB13156	Inosine pranobex	approved	0.7
